foscarnet and acyclovir

foscarnet has been researched along with acyclovir in 339 studies

Research

Studies (339)

TimeframeStudies, this research(%)All Research%
pre-199065 (19.17)18.7374
1990's116 (34.22)18.2507
2000's92 (27.14)29.6817
2010's51 (15.04)24.3611
2020's15 (4.42)2.80

Authors

AuthorsStudies
Duncan, IB; Hall, MJ; Heimer, EP; Lambert, RW; Martin, JA; Thomas, GJ1
Bobek, M; Cheng, YC; Dutschman, G; Grill, S; Kavai, I; Sharma, RA1
Burckhalter, JH; Drach, JC; Nasr, M; Shipman, C; Smith, SH1
De Clercq, E; Griengl, H; Hayden, W; Penn, G; Rosenwirth, B1
Breitenbach, JM; Devivar, RV; Drach, JC; Kawashima, E; Kreske, ED; Revankar, GR; Townsend, LB1
Cha, SH; Endou, H; Kanai, Y; Kimura, M; Sekine, T; Tsuda, M; Wada, S1
Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S1
Focher, F; Gambino, J; Gebhardt, BM; Lossani, A; Manikowski, A; Spadari, S; Verri, A; Wright, GE1
Brideau, RJ; Cudahy, MM; Homa, FL; Hopkins, TA; Knechtel, ML; Oien, NL; Pitts, TW; Poorman, RA; Schnute, ME; Wathen, MW; Wieber, JL1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Anderson, DJ; Brideau, RJ; Ciske, FL; Collier, SA; Cudahy, MM; Eggen, M; Genin, MJ; Hopkins, TA; Judge, TM; Kim, EJ; Knechtel, ML; Nair, SK; Nieman, JA; Oien, NL; Schnute, ME; Scott, A; Tanis, SP; Vaillancourt, VA; Wathen, MW; Wieber, JL1
Black, DH; Eberle, R; Focher, F; Gambino, JJ; Lossani, A; Maioli, A; Medveczky, M; Medveczky, P; Shugar, D; Spadari, S; Verri, A; Wright, GE1
Brideau, RJ; DiPaolo, BA; Hageman, MJ; Hopkins, TA; Knechtel, ML; Larsen, SD; Manninen, PR; Oien, NL; Rohrer, DC; Rush, BD; Schwende, FJ; Stefanski, KJ; Wathen, MW; Wieber, JL; Wilkinson, KF; Zamora, KM; Zhang, Z1
Lombardo, F; Obach, RS; Waters, NJ1
Brideau, RJ; Collier, SA; Cudahy, MM; Hopkins, TA; Knechtel, ML; Oien, NL; Sackett, RS; Schnute, ME; Scott, A; Stephan, ML; Wathen, MW; Wieber, JL1
Andrei, G; Balzarini, J; Camarasa, MJ; de Castro, S; Naesens, L; Peromingo, MT; Snoeck, R; Velázquez, S1
Hamprecht, K; Schott, H; Schott, S; Schott, TC; Schwendener, RA1
Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E1
Andrei, G; Balzarini, J; Camarasa, MJ; De Castro, S; García-Aparicio, C; Snoeck, R; Velázquez, S1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Daily, SL; Frederick, SL; Harden, EA; Hartline, CB; Jefferson, G; Kern, ER; Maddry, JA; Prichard, MN; Quenelle, DC; Secrist, JA; Tiwari, KN; Whitley, RJ1
Campillo, NE; Guerra, A; Páez, JA1
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV1
Hopkins, TA; Knechtel, ML; Moon, MW; Oien, NL; Parker, TT; Perrault, WR; Stephanski, KJ; Strohbach, JW; Tanis, SP; Thaisrivongs, S; Wathen, MW; Wieber, JL1
Chen, K; Heasley, SE; Hopkins, TA; Knechtel, ML; Nair, SK; Nieman, JA; Nugent, RA; Oien, NL; Schultz, BL; Stephanski, KJ; Wathen, MW; Wieber, JL; Zerth, HM1
Agut, H; Boutolleau, D; Burrel, S; Deback, C1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Coen, DM; Hwang, CB; Ruffner, KL1
Frissen, PH; Jansen, CL; Maris-Tegeler, WG; van der Noordaa, J; Weiland, HT; Wertheim-van Dillen, PM1
Cerrina, J; Le Roy Ladurie, F1
Birch, CJ; Doherty, R; Hayes, K; Lucas, CR; Mijch, A; Tachedjian, G; Tyssen, DP1
Coen, DM; Hicks, KA; Pelosi, E; Sacks, SL1
Lauchart, W1
Baratz, KH; Cobo, LM; Frothingham, R; Sonkin, PL1
Chen, ZJ; Liu, WG; Song, JZ1
David, F; Gerrier, F; Kateb, M; Modai, J; Molina, JM; Morinet, F; Schnell, L; Scieux, C1
Hardy, WD1
Seigneurin, JM1
Berger, TG; Biron, KK; Gilson, I; Mills, J; Safrin, S; Wofsy, CB; Wolfe, PR1
Angritt, P; Davis, C; James, WD; Kahlter, DC; Skelton, HG; Smith, KJ1
Chatis, P; Crumpacker, C; Davis, R; Hafner, R; Kessler, HA; Landry, B; Mills, J; Rush, J; Safrin, S1
Degré, M1
Bruun, JN; Moeland, A1
De Clercq, E; Himpens, B; Neyts, J; Schols, D; Snoeck, R1
Friberg, TR; Leeper, HF; Paul, AA1
Epstein, JB1
Choi, SS; Rasshofer, R; Roggendorf, M; Wölfl, P1
Arbesfeld, DM; Thomas, I1
Bratzke, B; Ehlers, G; Orfanos, CE; Stavermann, T1
Albrecht, H; Greten, H; Löning, T; Stellbrink, HJ1
Bevilacqua, F; Cusini, M; Gerna, G; Marcello, A; Palù, G; Toni, M; Zavattoni, M; Zerboni, R1
Cossart, YE; Freiman, JS; Lim, D; Murray, SM; Vickery, K1
Charmot, G; Coulaud, JP; De Truchis, P; Fegueux, S; Ingrand, D; Kernbaum, S; Simon, F1
Assaykeen, T; Follansbee, S; Mills, J; Safrin, S1
Charles, SJ; Gray, JJ1
Ellis, MN; Hackman, RC; Ljungman, P; Meyers, JD; Shepp, DH1
Birch, CJ; Doherty, RR; Gust, ID; Hayes, K; Tachedjian, G1
Meyers, JD; Reed, EC1
Bryson, YJ1
Drennan, DP; Erlich, KS; Follansbee, SE; Gooze, L; Jacobson, MA; Koehler, JE; Mills, J; Safrin, S1
Drennan, DP; Greenspan, D; MacPhail, LA; Mills, J; Schiødt, M1
Chatis, PA; Crumpacker, CS; Miller, CH; Schrager, LE1
Jacobson, MA; O'Donnell, JJ1
Azuma, M; Sakuma, T1
Chiba, S1
Pinching, AJ1
Agut, H; Collandre, H; Huraux, JM; Montagnier, L1
Acheson, JF; Bradbeer, C; Shah, SM; Spalton, DJ; Thin, RN1
Brunette, EN; DeBruin, M; Debs, RJ; Montgomery, AB; Shanley, JD1
Jacobson, MA; Mills, J1
Datema, R; Ericson, AC; Kristofferson, A; Sohl-Akerlund, A1
Meyers, JD1
Gonzales, MF; Greco, C; Jacobson, MA; Miller, RG; Mills, J; O'Donnell, JJ; Rush, J1
Bloom, JN; Palestine, AG1
Girard, PM; Le Hoang, P; Michon, C; Ngovan, P; Simonpoli, AM1
Akerfeldt, S; Bergman, J; Harmenberg, J; Lundblad, L; Wahren, B1
Herrmann, G; Reefschläger, J; Thiel, KD; Wutzler, P2
Al-Samarai, A; Kinghorn, G; Potter, C1
Collins, P; Evans, R; Hawkins, DA; Lawrence, A; Oliver, N; Shanson, DC; Youle, MM1
Harmenberg, JG; Svensson, LT1
Buck, CC; Loh, PC1
Freeman, DJ; Sheth, NV; Spruance, SL1
Collins, P; Tsiquaye, KN; Zuckerman, AJ1
Boogaerts, M; De Clerck, D; De Clercq, E; Vinckier, F1
Attanasio, R; Johnson, JC1
Ablashi, DV; Fullen, J; Hellman, K; Hung, CL; Salahuddin, SZ; Saxinger, C; Streicher, HZ1
Coen, DM; Fleming, HE; Leslie, LK; Retondo, MJ1
Fong, CK; Hsiung, GD; Mayo, DR; Winship, T; Zheng, ZM1
Dolin, R1
Ayisi, NK; Babiuk, LA; Gupta, SV1
Cheng, YC; Frank, KB1
Harmenberg, J; Levén, B; Sundqvist, VA; Wahren, B1
Brännström, G; Gadler, H; Harmenberg, J; Levén, B; Sundqvist, VA; Wahren, B1
Hall, MJ1
Clarke, JR; Davis, JM; Jeffries, DJ; Tyms, AS1
Bombail, D; Cavazzana, M; De Castro, H; Gluckman, E; Huart, JJ; Jolivet, I; Keable, H; Meletis, J; Nebout, T1
Abele, G; Harmenberg, J; Wahren, B1
Poryo, A; Wigand, R1
Matz, B; Schlehofer, JR; zur Hausen, H1
Nicholson, KG1
Kelley, E; Spector, SA; Tyndall, M2
Janz, C; Wigand, R1
Burkhardt, U; Wigand, R1
Brochier, B; Pastoret, PP; Schwers, A; Thiry, E; Vindevogel, H; Wérenne, J1
Friedman-Kien, AE; Klein, RJ1
Lycke, E; Svennerholm, B; Ziegler, R1
Hsiung, GD; Mayo, DR1
Darby, G; Field, H; McMillan, A1
Lycke, E; Svennerholm, B; Vahlne, A1
Oxford, JS1
Alenius, S; Berg, M; Broberg, F; Eklind, K; Lindborg, B; Oberg, B1
Klein, RJ1
Nahmias, AJ; Schinazi, RF1
Cheriyan, UO; Galloway, KS; Ogilvie, KK; Smith, KO1
Griffith, BP; Hsiung, GD; Lucia, HL1
Baba, M; De Clercq, E; Ito, M; Shigeta, S1
Li, YY; Minagawa, H; Mori, R; Tanaka, S1
Caliendo, AM; Hirsch, MS1
Olivo, PD; Stabell, EC; Tebas, P1
About, I; Bernard, P; Capdeville, J; Massip, P1
Costagliola, D; Mary-Krause, M1
Barnett, BB; Holy, A; Reist, EJ; Sidwell, RW; Smee, DF1
Jones, TJ; Paul, R1
Chu, SY; Hanson, DL; Jaffe, HW; Jones, JL; Ward, JW1
Bacigalupo, A; Frassoni, F; Gualandi, F; Lonngren, M; Moro, F; Occhini, D; Sanna, MA; Tedone, E; Trespi, G; Van Lint, MT1
Morris, DJ1
Andrei, G; Balzarini, J; Clumeck, N; De Clercq, E; Gérard, M; Hedderman, A; Sadzot-Delvaux, C; Silverman, A; Snoeck, R; Tricot, G1
Elbaggari, A; Elbeik, T; Mills, J; Phan, L; Robinson, D; Rush, J; Safrin, S1
Balfour, HH; Benson, C; Braun, J; Cassens, B; Erice, A; Friedman-Kien, A; Klein, T; Polsky, B; Safrin, S1
Reusser, P2
Elbeik, T; Mills, J; Safrin, S1
Bogner, JR; Geier, SA; Goebel, FD; Klauss, V; Sadri, I; Schmidt-Kittler, H1
Berens, RL; Cotton, M; Hayward, AR; Levin, MJ; Nyquist, AC; Robinson, C; Rotbart, HA; Weinberg, A1
Collins, P1
Phan, L; Safrin, S1
Zaia, JA2
Cohn, D; De Veranez, D; Kemmerly, S; Phan, LD; Plotkin, B; Safrin, S; Smith, T; Weissbach, N1
Baumann, R; Riess, C; Vogt, M; Wunderli, W1
Brun-Vezinet, F; Pépin, JM; Simon, F1
Engstrom, RE; Holland, GN; Johnston, WH; Rimmer, S1
Freifeld, AG1
Cornelissen, JJ; de Gast, GC; Dekker, AW; Lepoutre, J; Rozenberg-Arska, M; Smit, J; Verdonck, LF1
Sacks, SL; Sasadeusz, JJ1
Bianchi, A; Scieux, C1
Cheng, YC; Egan, W; Grill, S; Yao, GQ1
Caumes, E; Dumont, B; Fillet, AM; Gentilini, M; Huraux, JM; Visse, B1
Cohen, BA1
Detels, R; Glesby, MJ; Graham, NM; Ho, M; Hoover, DR; Phair, JP; Saah, AJ; Weng, S1
Avery, RK; Dodds, EM; Foster, RE; Lowder, CY; Prayson, RA1
Mahmood, W; Sacks, SL1
Bernhard, P; Obel, N1
Cordonnier, C; Einsele, H; Engelhard, D; Link, D; Ljungman, P; Locasciulli, A; Reusser, P1
Chandrasekar, PH; Naik, HR; Siddique, N1
Becker, BN; Schulman, G1
Castanet, J; Durant, J; Lacour, JP; Ortonne, JP; Perrin, C; Rodot, S; Van Elslande, L1
Leahy, BJ; Palacios, E; Safrin, S1
Andrei, G; De Clercq, E; Snoeck, R2
Gazzard, B; Halai, R; Mocroft, A; Morcinek, J; Phillips, AN; Youle, M1
Gondo, H; Iino, T; Iwasaki, H; Maruyama, T; Minagawa, H; Nakashima, H; Niho, Y; Ohno, Y1
Katz, A; Martin, DF; Spaide, RF; Teich, SA; Toth, I1
Asboe, D; Bingham, JS; Smith, NA; Wood, C1
Itin, PH; Lautenschlager, S1
Berger, BB; Fowell, SM; Jampol, LM; Kumar, S; Loose, IA; Minturn, JT; Moorthy, RS; Rao, NA; Teich, SA; Weinberg, DV1
Ganem, D; Kedes, DH1
Horvath, E; Lund, T; Medveczky, MM; Medveczky, PG1
Boggs, J; Cheung, T; Corey, L; Drew, WL; Feinberg, J; Gathe, J; Jaffe, HS; Kessler, H; Kramer, F; Lalezari, J; Lee, S; McGuire, B; Safrin, S; Schacker, T1
Aurelian, L; Beasley, KL; Burnett, JW; Cooley, GE; Kao, GF; Lowitt, MH1
Hampl, W; Hartmann, A; Mertens, T; Michel, D; Pavić, I; Schleyer, I; Zimmermann, A1
Einsele, H; Hebart, H; Jahn, G; Kanz, L1
Okada, S; Tanaka-Taya, K1
Bacigalupo, A; Barbanti, M; Corvo, R; Delfino, L; Ferrara, GB; Ficai, G; Frassoni, F; Ghinatti, C; Gualandi, F; Lamparelli, T; Morabito, A; Occhini, D; Pozzi, S; Sacchi, N; Van Lint, MT; Vitale, V; Zikos, P1
Hill, EL; Kern, ER; Koelle, DM; Lawrence, W; Posavad, CM; Safrin, S; Swetter, SM1
Cooney, EL; Gariano, RF; Lee, MS; Stoessel, KM1
Levine, JF; LoPresti, AE; Mendel, DB; Munk, GB; Tai, CY1
Barton, S; Scoular, A1
de Smet, MD; Meenken, C; van den Horn, GJ; van der Meer, JT1
Ciulla, TA; Duker, JS; Morley, MG; Rutledge, BK1
Bouscary, D; Chaine, B; Dreyfus, F; Fillet, AM; Ginsburg, C; Huraux, JM; Lesueur, A; Palmer, P; Salmon-Ceron, D; Sicard, D1
Darville, JM; Foot, AB; Ley, BE; Roome, AP1
Don, PC; Kaufmann, M; Lateef, F; Weinberg, JM; White, SM1
Harms, M; Krischer, J; Pechère, M; Saura, JH; Trellu-Toutous, L; Wunderli, W1
Aschan, J; Carlens, S; Larsson, K; Lewensohn-Fuchs, I; Ljungman, P; Lönnqvist, B; Mattsson, J; Ringdén, O; Sparrelid, E; Winiarski, J1
Breton, G; Bricaire, F; Caumes, E; Fillet, AM; Katlama, C1
Apperley, JF; Baccarani, M; Fanin, R; Stocchi, R; Ward, KN1
Chatelard, P; Iten, A; Meuli, R; Meylan, PR; Miklossy, J; Sahli, R; Vuadens, P1
Blauvelt, A; Chandran, B; Eyes, ST; Forghani, B; Kawamura, T; Orenstein, JM; Wu, L; Zoeteweij, JP1
Boivin, G; Schmit, I1
Bryson, Y; Grafford, K; Hardy, WD; Javaly, K; Kalayjian, R; Klein, T; Martin-Munley, S; Wohlfeiler, M1
Bouza, E; Catalán, P; Cercenado, E; Cotarelo, M; Menasalvas, A; Sánchez-Carrillo, C; Tenorio, A1
Nikkels, AF; Pierard, GE; Rentier, B; Snoeck, R1
Alvarez-McLeod, A; Drew, KE; Havlik, J1
Keating, MR1
Bergeron, MG; Désormeaux, A; Gourde, P; Juhász, J; Piret, J1
Andrei, G; De Clercq, E; Myhren, F; Neyts, J; Sandvold, ML; Snoeck, R1
Fong, IW; Fong, MW; Ho, J; Lo, B; Toy, C1
Bartolomé, B; Córdoba, S; Fernández-Herrera, J; Fraga, J; García-Díez, A1
Einsele, H; Hebart, H1
Dworkin, MS; Hanson, DL; Jaffe, HW; Jones, JL1
Bernstein, DI; Bourne, N; Ireland, J1
Agut, H; Bodaghi, B; Dighiero, P; Frau, E; Michelson, S; Mougin, C; Offret, H1
Mahendra, P; Osman, H; Tauro, S; Toh, V1
Aymard, M; Chen, Y; Devergie, A; Espérou, H; Garderet, L; Garrait, V; Gluckman, E; Hocqueloux, L; Leleu, G; Molina, JM; Morfin, F; Morinet, F; Ribaud, P; Rocha, V; Scieux, C; Sélimi, F; Socié, G; Thouvenot, D1
Blot, N; Dehesdin, D; Janvresse, C; Schneider, P; Tron, P; Vannier, JP; Young, P1
Brink, NS; Goldstone, AH; Kottaridis, PD; Linch, DC; Mackinnon, S; McKeag, N; Peggs, KS; Preiser, W; Tedder, RS1
Bertrand, Y; Claudy, A; Crassard, N; Morfin, F; Souillet, AL; Thouvenot, D1
Amjad, M; Carlson, RM; Gillespie, MA; Karim, MR1
Baker, R1
Bowers, M1
Spector, SA1
Ball, SC1
Balestra, E; Brand, G; Magnani, M; Perno, CF; Schiavano, GF; Tavazzi, B1
Fujiwara, T; Kaneko, H; Mori, S; Shigeta, S1
Bordigoni, P; Carret, AS; Corsaro, D; Dauendorffer, JN; Edert, D; Le Faou, A; Venard, V1
Bryant, P; Carapetis, J; Curtis, N; Sasadeusz, J; Waters, K1
Leary, JJ; Levin, MJ; Sarisky, RT; Weinberg, A1
Ait Arkoub, Z; Arnulf, B; Chebbi, F; Fillet, AM; Lefrere, F; Varet, B1
Allen, A; Bucur, S; Caliendo, AM; Cherry, J; Hutcherson, D; Langston, AA; Lonial, S; Redei, I; Somani, J; Waller, EK1
Cañizares, A; Guerrero, A; Hellín, T; Losada, I; Martí-Belda, P1
De Clercq, E; Naesens, L1
Gershon, AA1
Aoki, FY1
Aparicio Hernández-Lastras, MJ; Domingo Gordo, B; Luezas Morcuende, JJ; Suárez Leoz, M; Vidal Fernández, P1
Carrington, D; Cornish, JM; Foot, AB; Goulden, N; Marks, DI; Oakhill, A; Ronghe, MD; Steward, CG1
De Clercq, E; Kato, S; Kurane, I; Maeda, A; Morikawa, S; Niikura, M; Saijo, M; Suzutani, T; Yabe, H; Yasuda, Y1
Hedquist, B; Larsson, K; Ljungman, P; Lönnqvist, B; Ringdén, O1
Brown, TJ; McCrary, M; Tyring, SK1
Birch, C; Chibo, D; Doherty, R; Mijch, A1
Malkin, JE1
Emery, VC; Leśnikowski, ZJ; Olejniczak, A; Paradowska, E; Przepiórkiewicz, M1
Morfin, F; Thouvenot, D1
Benz, MS; Davis, JL; Glaser, JS1
Klammer, M; Kuhn, A; Ruzicka, T; Stege, H1
Shiraki, K1
Bidanset, DJ; Kern, ER; Kushner, NL; Long, MC; Williams, SL1
Bakker, HI; De Boer, FM; Harmsen, MC; Meijer, DK; Molema, G; van der Strate, BW1
Chilukuri, S; Rosen, T1
Aoyama, Y; Hasegawa, T; Hino, M; Kho, G; Makita, K; Nakamae, H; Ohta, K; Sakamoto, C; Shima, E; Takubo, T; Terada, Y; Yamamura, R; Yamane, T1
Boeckh, M; Nichols, WG; Papanicolaou, G; Rubin, R; Wingard, JR; Zaia, J1
Dahl, KM; Giller, R; Krause, PR; Levin, MJ; Patel, A; Weinberg, A1
Bodaghi, B; Cassoux, N; Chau Tran, TH; Lehoang, P1
Hwang, CB; Hwang, YT; Lu, Q; Zuccola, HJ1
Eksborg, S1
BhamBhani, K; Inaba, H; Meert, KL; Rabah, R1
Laroche, L; Larricart, P; Metge, F; Monin, C; Morel, C; Roman, S; Scheer, S1
Lajusticia, J; Ramos, C1
Clarke, HE; Maggs, DJ1
Bodaghi, B; Caspers-Velu, L; Gaudric, A; Lehoang, P; Liesnard, C; Rozenberg, F; Stanescu, D; Tran, TH1
Jollick, JA; Loef, C; Polman, M; Scholl, DR; Schuurman, R; Shaw, CJ; Stránská, R; van Loon, AM1
Biousse, V; Dorotheo, EU; Nakamoto, BK; Newman, NJ; Schiffman, JS; Tang, RA1
Diaz, GA; Koelle, DM; Rakita, RM1
Callé, A; Cayre, M; Diaz, JJ; Greco, A; Kindbeiter, K; Levillain, O; Martin, L; Morfin, F; Thouvenot, D1
Dediulescu, DF; Dediulescu, L1
Charonis, A; Gupta, A; Khurana, RN; Samuel, MA; Tawansy, KA1
Castilla, V; Galagovsky, LR; Ramirez, JA; Talarico, LB; Wachsman, MB1
Agut, H; Ait-Arkoub, Z; Bonnafous, P; Deback, C; Malet, I; Thi, TN1
Brummitt, CF1
Goh, CL; Tan, HH1
Alessi, E; Cusini, M; Ghislanzoni, M; Zerboni, R1
Croubels, S; De Backer, P; Garré, B; Nauwynck, H; Neyts, J; Nugent, J; van der Meulen, K1
Busche, C; Encke, J; Ganner, A; Gerke, P; Lee, YM; Schmitt-Graeff, A; Walz, G1
Boivin, G; Sergerie, Y1
Almony, A; Dhalla, MS; Feiner, L; Shah, GK1
Alsuwaidi, A; Hatchette, T; Mailman, TL; Peters, G; Tipples, GA; Zhou, J1
Kim, SJ; Lo, WR1
de Vries, RD; Duan, R; Osterhaus, AD; Remeijer, L; Verjans, GM1
Járay, J; Péter, A; Telkes, G; Varga, M1
Boeckh, MJ; Pergam, SA; Travi, G; Xie, H1
Galegov, GA; L'vov, ND; Mel'nichenko, AV1
Götte, M; Obikhod, A; Schinazi, RF; Tchesnokov, EP1
Graham, EM; Laidlaw, DA; Pavesio, CE; Stanford, MR; Williamson, TH; Wong, R1
Deinhardt, S; Sauerbrei, A; Wutzler, P; Zell, R1
Laibson, PR1
Bleymehl, K; Cinatl, J; Schmidt-Chanasit, J1
Balraj, P; Chu, WL; Khoo, AS; Kok, YY; Lai, PJ; Lim, PK; Ling, SN; Mak, JW; Mohamed, SM; Naidu, R; Phang, SM1
Doublié, S; Götte, M; Tchesnokov, EP; Zahn, KE1
Kim, KS; Lee, MY; Lee, WK1
Collin, M; Crowley, B; Jackson, G; Lee, D; Moses, SE; Osborne, W; Parry, CM; Valappil, M; Waugh, S1
Razonable, RR1
Bohn, K; Hamprecht, K; Heim, A; Hoffmann, D; Hofmann, J; Jahn, G; Sauerbrei, A; Schnitzler, P; Weissbrich, B; Wutzler, P; Zell, R1
Agut, H; Caumes, E; Challine, D; Deback, C; Lascaux, AS; Lévy, Y; Melica, G1
Blaschke, D; Boldt, LH; Haverkamp, W; Huemer, M; Parwani, A; Rolf, S; Wutzler, A1
Armistead, P; Dean, A; Khan, T; Muluneh, B1
Claas, EC; Kroes, AC; Morfin, F; Rusman, LG; van der Beek, MT; van der Blij-de Brouwer, CS; Vossen, AC1
Agut, H; Aime, C; Ait-Arkoub, Z; Boutolleau, D; Burrel, S; Hermet, L1
Bastide, C; Bruyère, F; Chandenier, J; Desoubeaux, G; Fourcade, C; Guy, L; Karsenty, G; Lachaud, L; Lavigne, JP; Malavaud, S; Sotto, A1
Andrei, G; Bier, JC; David, P; Delforge, ML; Fiten, P; Gillemot, S; Hernandez, A; Jacobs, F; Opdenakker, G; Schepers, K; Snoeck, R1
Agut, H; Boutolleau, D; Burrel, S; Caumes, E; Epelboin, L; Katlama, C; Regnier, S; Seang, S; Valantin, MA; Voujon, D1
Boivin, G; Piret, J1
Arnold, RD; Chavre, S; Chu, CK; De, C; Hagen, FK; Liu, D; Moffat, JF; Singh, US; White, C; Zheng, B1
Jorgensen, S; Langer, J; Prichard, M; Schlaberg, R; Tardif, KD1
Andrei, G; Coen, N; Duraffour, S; Snoeck, R; Topalis, D1
Boivin, G; Drouot, E; Eckenroth, BE; Götte, M; Goyette, N; Piret, J1
Andronova, VL; Deryabin, PG; Galegov, GA; Jasko, MV; Kukhanova, MK; Skoblov, YS1
Bohn-Wippert, K; Sauerbrei, A; Schlattmann, P; Schmidt, S; Zell, R1
Le, TD; Mandelcorn, ED; Weisbrod, D1
Kuchta, RD; Vashishtha, AK1
Ariza-Heredia, EJ; Foo, WC; Gutierrez, C; Kebriaei, P; Turner, KA; Yemelyanova, A1
Hartline, CB; Larson, RA; Mommeja-Marin, H; Mullane, KM; Nuss, C; Prichard, MN; Ridgeway, J; Theusch, J1
Edelmann, A; Hofmann, J; Kühl, JS; Sauerbrei, A; Voigt, S1
Beer, R; Bergmann, M; Helbok, R; Kofler, M; Pfausler, B; Schmutzhard, E1
Bakri, SJ; Ehlers, JP; Kim, SJ; Mruthyunjaya, P; Schoenberger, SD; Thorne, JE; Yeh, S1
Iseki, T; Kawajiri, C; Mimura, N; Muto, T; Nagao, Y; Nakaseko, C; Ohwada, C; Sakai, S; Sakaida, E; Shimizu, R; Takeda, Y; Takeuchi, M; Togasaki, E; Tsukamoto, S1
Rosen, T1
Debruxelles, S; Poli, M; Renou, P; Rouanet, F; Sagnier, S; Sibon, I1
Andronova, VL; Charushin, VN; Denisova, AO; Galegov, GA; Kayushin, AL; Kharitonova, MI; Konstantinova, ID; Kotovskaya, SK; Miroshnikov, AI1
Aoki, M; Fukae, J; Kimura, S; Nabeshima, K; Ogura, H; Tsuboi, Y1
Arinze, F; Raffanti, S; Shaver, A1
Espinoza, LA; Gonzales Zamora, JA1
Andrei, G; Gillemot, S; Snoeck, R; Topalis, D1
Bulai Livideanu, C; Casassa, EA; Fortenfant, F; Gaudin, C; Konstantinou, MP; Lamant, L; Mengelle, C; Nicol, P; Paul, C; Viraben, R1
Araki, R; Fujiki, A; Fujiki, T; Fukuda, M; Ikawa, Y; Koshino, E; Kuroda, R; Maeba, H; Mase, S; Nishimura, R; Noguchi, K; Shiraki, K; Yachie, A1
Aydin Teke, T; Gayretli Aydin, ZG; Genc Sel, C; Kaman, A; Tanir, G; Tasci Yıldız, Y1
Sinkó, J1
Kobayashi, T; Meier, J; Sekar, P; Streit, J1
Heidenreich, D; Hofmann, WK; Jawhar, M; Klein, SA; Kreil, S; Mueller, N; Nolte, F1
Boutolleau, D; Burrel, S; Topalis, D1
Byun, SS; Spaide, RF1
Moutran-Barroso, H; Rivera, JS; Toro, J; Valencia-Enciso, N1
Botsford, BW; Eller, AW; Nguyen, VQ1
Baukmann, S; Brunnemann, AK; Bühler, S; Fickenscher, H; Krumbholz, A; Rose, R; Sauerbrei, A; Zell, R1
Hopkins, CR; Lee, G; Lowe, N1
Harte, M; Ion, D; Saunsbury, T1
Bouscarat, F; Boutolleau, D; Bucau, M; Burrel, S; Fidouh, N; Ghosn, J; Hachon, L; Joly, V; Khellaf, L; Lariven, S; Le Pluart, D; Thy, M1
Andrei, G; Gillemot, S; Reynders, M; Schalkwijk, HH; Selleslag, D; Snoeck, R1
Kotton, BD; Kotton, CN1
Akça, M; Çobanoğulları Direk, M; Ersoy, Ö; Kuyucu, N; Özgökçe Özmen, B1
Fang, L; Li, L; Liang, B; Yan, C; Zhang, Y; Zhou, Y1
Ader, F; Billaud, G; Boyer, T; Destras, G; Ducastelle, S; Frobert, E; Ginevra, C; Giorgi, J; Josset, L; Morfin, F; Regue, H; Semanas, Q; Simon, B1
Glasgow, HL; Greninger, AL; Huang, ML; Kenkel, EJ; Lee, C; Xie, H; Zhu, H1

Reviews

61 review(s) available for foscarnet and acyclovir

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
[Cytomegalovirus infection in patients after lung transplantation].
    Presse medicale (Paris, France : 1983), 1992, Mar-21, Volume: 21, Issue:11

    Topics: Acyclovir; Antiviral Agents; Blood Transfusion; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immune Tolerance; Incidence; Lung Transplantation; Phosphonoacetic Acid; Prevalence; Viral Vaccines

1992
[Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii pneumonia after liver transplantation].
    Medizinische Klinik (Munich, Germany : 1983), 1992, Volume: 87 Suppl 1

    Topics: Acyclovir; Combined Modality Therapy; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Liver Transplantation; Opportunistic Infections; Pentamidine; Pneumonia, Pneumocystis; Pneumonia, Viral; Trimethoprim, Sulfamethoxazole Drug Combination

1992
[Antiviral agents for the systemic treatment of herpesvirus infections].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Sep-10, Volume: 111, Issue:21

    Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Phosphonoacetic Acid

1991
[Treatment of herpesvirus infections].
    Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1991, Sep-20, Volume: 111, Issue:22

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Phosphonoacetic Acid

1991
Antiviral therapeutics in dentistry.
    Current opinion in dentistry, 1991, Volume: 1, Issue:4

    Topics: Acyclovir; Antiviral Agents; Dental Care; Drug Combinations; Drug Resistance, Microbial; Foscarnet; Herpesviridae Infections; Humans; Immunocompromised Host; Interferons; Nucleosides; Phosphonoacetic Acid; Viral Vaccines

1991
Cutaneous herpes simplex virus infections.
    American family physician, 1991, Volume: 43, Issue:5

    Topics: Acyclovir; Administration, Oral; Antiviral Agents; Diagnosis, Differential; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Idoxuridine; Infusions, Intravenous; Phosphonoacetic Acid; Recurrence; Skin Diseases, Infectious; Trifluridine; Vidarabine

1991
Treatment of cytomegalovirus infection.
    Clinics in laboratory medicine, 1987, Volume: 7, Issue:4

    Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid

1987
Promising new antiviral drugs.
    Journal of the American Academy of Dermatology, 1988, Volume: 18, Issue:1 Pt 2

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Herpes Simplex; Herpes Zoster; Humans; Interferons; Phosphonoacetic Acid; Ribavirin; Thymidine; Zidovudine

1988
Cotton-wool spots and cytomegalovirus retinitis in AIDS.
    International ophthalmology clinics, 1989,Summer, Volume: 29, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Infections; Diabetic Retinopathy; Diagnosis, Differential; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Pneumocystis; Prognosis; Retinal Diseases; Retinitis; Zidovudine

1989
Cytomegalovirus infection in the acquired immune deficiency syndrome.
    The Journal of antimicrobial chemotherapy, 1989, Volume: 23 Suppl E

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Addison Disease; Antiviral Agents; Colitis; Cytomegalovirus Infections; Encephalitis; Esophageal Diseases; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis

1989
Serious cytomegalovirus disease in the acquired immunodeficiency syndrome (AIDS). Clinical findings, diagnosis, and treatment.
    Annals of internal medicine, 1988, Volume: 108, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Gastroenteritis; Humans; Opportunistic Infections; Phosphonoacetic Acid; Pneumonia, Viral; Retinitis

1988
Management of cytomegalovirus infection.
    The American journal of medicine, 1988, Aug-29, Volume: 85, Issue:2A

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Pneumonia, Viral

1988
The diagnosis of cytomegalovirus retinitis.
    Annals of internal medicine, 1988, Dec-15, Volume: 109, Issue:12

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Diagnosis, Differential; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Opportunistic Infections; Phosphonoacetic Acid; Retinitis; Vision Disorders

1988
[Treatment of cytomegalovirus infections in immunosuppressed patients].
    Annales de medecine interne, 1988, Volume: 139, Issue:7

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunologic Deficiency Syndromes; Organophosphorus Compounds; Phosphonoacetic Acid

1988
[Etiological therapeutics in viral diseases].
    Annales de recherches veterinaires. Annals of veterinary research, 1984, Volume: 15, Issue:1

    Topics: Acyclovir; Amantadine; Animals; Antibodies, Viral; Antiviral Agents; Chemical Phenomena; Chemistry; Foscarnet; Idoxuridine; Immunity, Cellular; Immunity, Innate; Immunotherapy; Interferons; Phosphonoacetic Acid; Vidarabine; Virus Diseases; Virus Replication

1984
Treatment of experimental latent herpes simplex virus infections with acyclovir and other antiviral compounds.
    The American journal of medicine, 1982, Jul-20, Volume: 73, Issue:1A

    Topics: Acyclovir; Animals; Antiviral Agents; Culture Techniques; Foscarnet; Ganglia; Guanine; Herpes Simplex; Mice; Neurons; Phosphonoacetic Acid; Simplexvirus; Time Factors

1982
Combination therapy for infection due to human immunodeficiency virus type 1.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:4

    Topics: Acyclovir; Antiviral Agents; CD4 Antigens; Clinical Trials as Topic; Combined Modality Therapy; Didanosine; Drug Therapy, Combination; Foscarnet; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; In Vitro Techniques; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine

1994
Adverse effects and drug interactions of clinical importance with antiviral drugs.
    Drug safety, 1994, Volume: 10, Issue:4

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Amantadine; Antiviral Agents; Didanosine; Drug Interactions; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Vidarabine; Zalcitabine; Zidovudine

1994
Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections.
    Journal of acquired immune deficiency syndromes, 1994, Volume: 7, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Algorithms; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Immunocompromised Host; Male; Recurrence; Simplexvirus; Trifluridine; Vidarabine

1994
Mechanisms of herpes virus resistance.
    Annals of medicine, 1993, Volume: 25, Issue:5

    Topics: Acyclovir; Animals; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Humans

1993
Prevention and treatment of cytomegalovirus pneumonia in transplant recipients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1993, Volume: 17 Suppl 2

    Topics: Acyclovir; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunoglobulins, Intravenous; Lung Diseases, Interstitial; Organ Transplantation; Pneumonia; Transplantation

1993
[Is resistance of human immunodeficiency viruses (HIV) to nucleoside analogs an indication for their combined use?].
    Pathologie-biologie, 1993, Volume: 41, Issue:8 Pt 2

    Topics: Acyclovir; Didanosine; Drug Synergism; Drug Therapy, Combination; Female; Foscarnet; HIV-1; Humans; In Vitro Techniques; Male; Ribavirin; Zalcitabine; Zidovudine

1993
Infectious complications in the immunocompromised host. The antimicrobial armamentarium.
    Hematology/oncology clinics of North America, 1993, Volume: 7, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiprotozoal Agents; Azoles; Aztreonam; Cephalosporins; Fluoroquinolones; Foscarnet; Ganciclovir; Humans; Imipenem; Immunocompromised Host; Infections; Neoplasms; Pneumonia, Pneumocystis; Vancomycin

1993
Systemic antivirals in herpesvirus infections.
    Dermatologic clinics, 1993, Volume: 11, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Animals; Antiviral Agents; Clinical Trials as Topic; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Vidarabine

1993
[Resistance of herpes simplex viruses to antiviral drugs].
    Pathologie-biologie, 1993, Volume: 41, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; In Vitro Techniques; Simplexvirus; Thymidine Kinase; Vidarabine

1993
Anti-infective therapy for viral pneumonia.
    Seminars in respiratory infections, 1995, Volume: 10, Issue:4

    Topics: Acyclovir; Amantadine; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Neuraminidase; Pneumonia, Viral; Ribavirin; Rimantadine

1995
Nephrotoxicity of antiviral therapies.
    Current opinion in nephrology and hypertension, 1996, Volume: 5, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunoglobulins, Intravenous; Influenza, Human; Interferon Type I; Kidney; Recombinant Proteins; Reverse Transcriptase Inhibitors

1996
Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options.
    The Journal of hospital infection, 1996, Volume: 33, Issue:4

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae; Herpesviridae Infections; Humans; Immunocompromised Host; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine

1996
Viral lesions of the mouth in HIV-infected patients.
    Dermatology (Basel, Switzerland), 1997, Volume: 194, Issue:1

    Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cytomegalovirus Infections; Disease Progression; Famciclovir; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Leukoplakia, Hairy; Lymphoma, B-Cell; Lymphoma, T-Cell; Molluscum Contagiosum; Mouth Diseases; Mouth Neoplasms; Oral Ulcer; Prodrugs; Sarcoma, Kaposi; Stomatitis, Herpetic; Tumor Virus Infections; Valacyclovir; Valine; Virus Diseases; Warts

1997
Management of cytomegalovirus infection after solid-organ or stem-cell transplantation. Current guidelines and future prospects.
    Drugs, 1998, Volume: 55, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Guidelines as Topic; Hematopoietic Stem Cell Transplantation; Humans; Organ Transplantation

1998
[Human herpesvirus-6 and -7 infection and bone marrow transplantation (BMT)].
    Nihon rinsho. Japanese journal of clinical medicine, 1998, Volume: 56, Issue:1

    Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Bone Marrow Transplantation; Foscarnet; gamma-Globulins; Ganciclovir; Herpesviridae Infections; Herpesvirus 6, Human; Herpesvirus 7, Human; Humans; Immunocompromised Host; Polymerase Chain Reaction

1998
Management of human cytomegalovirus infection and disease after allogeneic bone marrow transplantation.
    Haematologica, 1999, Volume: 84, Issue:1

    Topics: Acyclovir; Adolescent; Adult; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunoglobulins, Intravenous; Immunotherapy, Adoptive; Infant; Pneumonia, Viral; Risk Factors; Sensitivity and Specificity; T-Lymphocytes, Cytotoxic; Transplantation Conditioning; Transplantation, Homologous; Viral Vaccines; Viremia; Virus Activation

1999
Chronic verrucous varicella zoster virus skin lesions: clinical, histological, molecular and therapeutic aspects.
    Clinical and experimental dermatology, 1999, Volume: 24, Issue:5

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpesvirus 3, Human; HIV Infections; Humans; Skin Diseases, Viral

1999
Antiviral agents for non-human immunodeficiency virus infections.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:12

    Topics: 2-Aminopurine; Acetamides; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drugs, Investigational; Enzyme Inhibitors; Famciclovir; Foscarnet; Ganciclovir; Guanidines; Guanine; Humans; Interferons; Lamivudine; Neuraminidase; Organophosphonates; Organophosphorus Compounds; Oseltamivir; Pyrans; Ribavirin; Sialic Acids; Valacyclovir; Valine; Virus Diseases; Zanamivir

1999
Cytomegalovirus infection following stem cell transplantation.
    Haematologica, 1999, Volume: 84 Suppl EHA-4

    Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Blood Donors; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Hematopoietic Stem Cells; Humans; Immunocompromised Host; Immunotherapy, Adoptive; Leukocyte Transfusion; Organophosphonates; Organophosphorus Compounds; Premedication; Risk Factors; Tissue Donors; Transfusion Reaction; Virus Latency

1999
Persistent herpes simplex virus infection.
    The AIDS reader, 2001, Volume: 11, Issue:5

    Topics: Acyclovir; Adult; Female; Foscarnet; Herpes Labialis; HIV Infections; Humans; Immunocompromised Host; Practice Guidelines as Topic

2001
Recent developments in herpesvirus therapy.
    Herpes : the journal of the IHMF, 2001, Volume: 8, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Clinical Trials as Topic; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Humans; Organophosphonates; Organophosphorus Compounds; Thionucleotides; Valacyclovir; Valine

2001
Prevention and treatment of VZV infections in patients with HIV.
    Herpes : the journal of the IHMF, 2001, Volume: 8, Issue:2

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chickenpox; Chickenpox Vaccine; Child; Foscarnet; Herpesvirus 3, Human; Humans; Prospective Studies; Risk Factors

2001
Management of genital herpes in HIV-infected patients.
    Herpes : the journal of the IHMF, 2001, Volume: 8, Issue:2

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Antiviral Agents; Drug Resistance; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Recurrence; Risk Factors; Simplexvirus; Vidarabine

2001
Prevention and management of CMV-related problems after hematopoietic stem cell transplantation.
    Bone marrow transplantation, 2002, Volume: 29, Issue:8

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Risk Factors

2002
Antiviral agents: Non-antiretroviral [correction of Nonantiviral] drugs.
    Journal of the American Academy of Dermatology, 2002, Volume: 47, Issue:4

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Chickenpox; Cytomegalovirus Infections; Famciclovir; Foscarnet; Guanine; Hepatitis B; Hepatitis C; Herpes Genitalis; Herpes Simplex; Herpesvirus 3, Human; Herpesvirus 8, Human; Humans; Papillomavirus Infections; Sarcoma, Kaposi; Skin Diseases, Viral; Valacyclovir; Valine

2002
[Drugs against human cytomegalovirus].
    Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 2002, Volume: 13, Issue:75

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drugs, Investigational; Female; Foscarnet; Ganciclovir; Global Health; Humans; Infectious Disease Transmission, Vertical; Naphthalenesulfonates; Organophosphonates; Organophosphorus Compounds; Pregnancy; Pregnancy Complications, Infectious; Thionucleotides; Valacyclovir; Valganciclovir; Valine

2002
Herpes simplex virus resistance to antiviral drugs.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2003, Volume: 26, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Enzyme Inhibitors; Exodeoxyribonucleases; Foscarnet; Herpes Simplex; Humans; Immunocompromised Host; Mutation; Nucleic Acid Synthesis Inhibitors; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Thymidine Kinase; Viral Proteins; Virus Replication

2003
[Anti-herpetic chemotherapeutic drugs].
    Nihon rinsho. Japanese journal of clinical medicine, 2003, Volume: 61 Suppl 2

    Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpesviridae; Herpesviridae Infections; Humans; Idoxuridine; Protein Kinase Inhibitors; Thymidine Kinase; Valacyclovir; Valine; Vidarabine

2003
Management of acyclovir-resistant herpes simplex virus.
    Dermatologic clinics, 2003, Volume: 21, Issue:2

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Humans; Organophosphonates; Organophosphorus Compounds; Stomatitis, Herpetic; Trifluridine; Vidarabine

2003
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2003, Volume: 9, Issue:9

    Topics: Acyclovir; Antigens, CD34; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunoglobulins, Intravenous; Immunosuppression Therapy; Immunotherapy; Lymphocyte Depletion; Organophosphonates; Organophosphorus Compounds; Transplantation Conditioning

2003
The pharmacokinetics of antiviral therapy in paediatric patients.
    Herpes : the journal of the IHMF, 2003, Volume: 10, Issue:3

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Child; Child, Hospitalized; Cidofovir; Cytosine; Famciclovir; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Virus Diseases

2003
Clinical characteristics of acute HSV-2 retinal necrosis.
    American journal of ophthalmology, 2004, Volume: 137, Issue:5

    Topics: Acyclovir; Adult; Antiviral Agents; Aqueous Humor; Child; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 2, Human; Humans; Interferons; Male; Middle Aged; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Virus Activation; Visual Acuity; Vitreous Body

2004
Progressive outer retinal necrosis presenting with isolated optic neuropathy.
    Neurology, 2004, Dec-28, Volume: 63, Issue:12

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Diagnostic Errors; Diplopia; Disease Progression; Encephalitis, Viral; Female; Foscarnet; Herpes Zoster; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Necrosis; Optic Neuritis; Paresis; Prednisone; Retina

2004
[Antiherpetic therapy].
    Oftalmologia (Bucharest, Romania : 1990), 2005, Volume: 49, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Bromodeoxyuridine; Cidofovir; Cytosine; Drug Combinations; Famciclovir; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Herpetic; Oligonucleotides; Ophthalmic Solutions; Organophosphonates; Treatment Outcome; Valacyclovir; Valine; Vidarabine

2005
Viral infections affecting the skin in organ transplant recipients: epidemiology and current management strategies.
    American journal of clinical dermatology, 2006, Volume: 7, Issue:1

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus Infections; Cytosine; Drug Administration Schedule; Epstein-Barr Virus Infections; Famciclovir; Foscarnet; Herpes Zoster; Herpesviridae Infections; Humans; Immunocompromised Host; Molluscum Contagiosum; Organ Transplantation; Organophosphonates; Papillomavirus Infections; Skin Diseases, Viral; Trifluridine; Valacyclovir; Valine

2006
Foscarnet salvage therapy for acyclovir-resistant varicella zoster: report of a novel thymidine kinase mutation and review of the literature.
    The Pediatric infectious disease journal, 2008, Volume: 27, Issue:1

    Topics: Acyclovir; Chickenpox; Child; Drug Resistance, Viral; Female; Foscarnet; Herpesvirus 3, Human; Humans; Microbial Sensitivity Tests; Mutation; Salvage Therapy; Thymidine Kinase

2008
[Gastrointestinal cytomegalovirus infections in organ transplant patients].
    Orvosi hetilap, 2008, Dec-21, Volume: 149, Issue:52

    Topics: Acyclovir; Antiviral Agents; Biopsy; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Endoscopy, Gastrointestinal; Foscarnet; Ganciclovir; Gastric Mucosa; Gastrointestinal Diseases; Gastrointestinal Tract; Humans; Immunocompromised Host; Immunoglobulins; Immunotherapy, Adoptive; Intestinal Mucosa; Organ Transplantation; Organophosphonates; Primary Prevention; Valganciclovir

2008
Antiviral drugs for viruses other than human immunodeficiency virus.
    Mayo Clinic proceedings, 2011, Volume: 86, Issue:10

    Topics: Acyclovir; Adenine; Amantadine; Antiviral Agents; Comorbidity; Drug Therapy, Combination; Foscarnet; Ganciclovir; Guanine; Hepatitis; Hepatitis B, Chronic; Hepatitis C; Herpesviridae Infections; HIV Infections; Humans; Influenza, Human; Interferons; Lamivudine; Nucleosides; Oligopeptides; Organophosphonates; Oseltamivir; Proline; Protease Inhibitors; Pyrimidinones; Ribavirin; Telbivudine; Thymidine; Valacyclovir; Valganciclovir; Valine; Virus Replication; Zanamivir

2011
[Non-antibiotic anti-infectious treatments in urology].
    Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie, 2013, Volume: 23, Issue:15

    Topics: Acyclovir; Albendazole; Amphotericin B; Anti-Infective Agents; Caspofungin; Cidofovir; Cytosine; Echinocandins; Fluconazole; Flucytosine; Foscarnet; Ganciclovir; Humans; Ivermectin; Lipopeptides; Organophosphonates; Praziquantel; Urologic Diseases; Valganciclovir

2013
Antiviral drug resistance in herpesviruses other than cytomegalovirus.
    Reviews in medical virology, 2014, Volume: 24, Issue:3

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; Drug Resistance, Viral; Foscarnet; Ganciclovir; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 3, Human; Herpesvirus 6, Human; Humans; Immunocompromised Host; Organophosphonates

2014
Diagnosis and Treatment of Acute Retinal Necrosis: A Report by the American Academy of Ophthalmology.
    Ophthalmology, 2017, Volume: 124, Issue:3

    Topics: Academies and Institutes; Acyclovir; Antiviral Agents; Aqueous Humor; Biomedical Technology; DNA, Viral; Eye Infections, Viral; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Ophthalmology; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; United States; Valacyclovir; Valine; Vitrectomy; Vitreous Body

2017
Acyclovir resistant acute herpes simplex encephalitis associated with acute retinal necrosis: A case report and review of the literature.
    Rinsho shinkeigaku = Clinical neurology, 2017, 05-27, Volume: 57, Issue:5

    Topics: Acute Disease; Acyclovir; Antiviral Agents; Disease Progression; Drug Resistance, Viral; Encephalitis, Herpes Simplex; Foscarnet; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Retinal Necrosis Syndrome, Acute; Treatment Failure; Treatment Outcome

2017
[Current treatment modalities of immunocompromised patients with cytomegalovirus infection. II. Therapeutic options and management strategies].
    Orvosi hetilap, 2019, Volume: 160, Issue:10

    Topics: Acetates; Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunocompromised Host; Quinazolines; Stem Cell Transplantation

2019
Resistant herpes simplex virus infections - who, when, and what's new?
    Current opinion in infectious diseases, 2022, 12-01, Volume: 35, Issue:6

    Topics: Acyclovir; Antiviral Agents; Cytosine; Foscarnet; Herpes Simplex; Herpesviridae Infections; Humans; Organophosphonates

2022

Trials

9 trial(s) available for foscarnet and acyclovir

ArticleYear
Foscarnet treatment of acyclovir-resistant herpes simplex virus infection in patients with acquired immunodeficiency syndrome: preliminary results of a controlled, randomized, regimen-comparative trial.
    The American journal of medicine, 1992, Feb-14, Volume: 92, Issue:2A

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid

1992
A controlled trial comparing foscarnet with vidarabine for acyclovir-resistant mucocutaneous herpes simplex in the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group.
    The New England journal of medicine, 1991, Aug-22, Volume: 325, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Humans; Male; Phosphonoacetic Acid; Recurrence; Simplexvirus; Stomatitis, Herpetic; Vidarabine

1991
Treatment of cytomegalovirus infection.
    Clinics in laboratory medicine, 1987, Volume: 7, Issue:4

    Topics: Acyclovir; Clinical Trials as Topic; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Interferons; Nucleosides; Phosphonoacetic Acid

1987
Antiviral chemotherapy and chemoprophylaxis.
    Science (New York, N.Y.), 1985, Mar-15, Volume: 227, Issue:4692

    Topics: Acyclovir; Adult; Aged; Amantadine; Antiviral Agents; Chickenpox; Clinical Trials as Topic; Cytomegalovirus; Encephalitis; Foscarnet; Guanosine Triphosphate; Herpes Simplex; Herpes Zoster; Herpesviridae Infections; Humans; Infant, Newborn; Infant, Newborn, Diseases; Influenza A virus; Influenza, Human; Phosphonoacetic Acid; Respiratory Tract Infections; Ribavirin; Rimantadine; Vidarabine; Virus Diseases

1985
CMV prophylaxis with foscarnet in allogeneic bone marrow transplant recipients at high risk of developing CMV infections.
    Bone marrow transplantation, 1994, Volume: 13, Issue:6

    Topics: Acyclovir; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Foscarnet; Humans; Male; Middle Aged; Pilot Projects; Risk Factors; Transplantation, Homologous

1994
Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study.
    The Journal of infectious diseases, 1996, Volume: 173, Issue:6

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bisexuality; Case-Control Studies; Foscarnet; Ganciclovir; Herpesviridae Infections; Homosexuality, Male; Humans; Longitudinal Studies; Male; Risk; Sarcoma, Kaposi

1996
Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
    AIDS (London, England), 1996, Volume: 10, Issue:10

    Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Disease Progression; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Infections; Humans; Male; Middle Aged; Proportional Hazards Models; Sarcoma, Kaposi

1996
A randomized, double-blind, placebo-controlled trial of cidofovir gel for the treatment of acyclovir-unresponsive mucocutaneous herpes simplex virus infection in patients with AIDS.
    The Journal of infectious diseases, 1997, Volume: 176, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Cidofovir; Cytosine; Double-Blind Method; Drug Resistance, Microbial; Female; Foscarnet; Gels; Herpes Simplex; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Vero Cells

1997
Treatment of mucocutaneous herpes simplex virus infections unresponsive to acyclovir with topical foscarnet cream in AIDS patients: a phase I/II study.
    Journal of acquired immune deficiency syndromes (1999), 1999, Aug-01, Volume: 21, Issue:4

    Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Eruptions; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Middle Aged; Safety; Skin Ulcer

1999

Other Studies

270 other study(ies) available for foscarnet and acyclovir

ArticleYear
Synthesis and antiviral activity of phosphonoacetic and phosphonoformic acid esters of 5-bromo-2'-deoxyuridine and related pyrimidine nucleosides and acyclonucleosides.
    Journal of medicinal chemistry, 1989, Volume: 32, Issue:2

    Topics: Antiviral Agents; Bromodeoxyuridine; Foscarnet; Organophosphorus Compounds; Phosphonoacetic Acid

1989
Acetylenic nucleosides. 4. 1-beta-D-arabinofuranosyl-5-ethynylcytosine. Improved synthesis and evaluation of biochemical and antiviral properties.
    Journal of medicinal chemistry, 1987, Volume: 30, Issue:11

    Topics: Antiviral Agents; Cytarabine; Deamination; Phosphorylation; Simplexvirus

1987
7-Aminoquinolines. A novel class of agents active against herpesviruses.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:7

    Topics: Aminoquinolines; Antiviral Agents; Cell Line; Cell Survival; Chemical Phenomena; Chemistry; DNA; Protein Biosynthesis; Simplexvirus; Structure-Activity Relationship; Viral Proteins; Virus Replication

1988
Phosphonoformate and phosphonoacetate derivatives of 5-substituted 2'-deoxyuridines: synthesis and antiviral activity.
    Journal of medicinal chemistry, 1988, Volume: 31, Issue:9

    Topics: Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chemical Phenomena; Chemistry; Deoxyuridine; Foscarnet; Herpes Simplex; Mice; Organophosphorus Compounds; Pharmaceutical Preparations; Phosphonoacetic Acid; Prodrugs; Rabbits; Simplexvirus; Thymidine; Vero Cells

1988
Benzimidazole ribonucleosides: design, synthesis, and antiviral activity of certain 2-(alkylthio)- and 2-(benzylthio)-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazoles.
    Journal of medicinal chemistry, 1994, Sep-02, Volume: 37, Issue:18

    Topics: Antiviral Agents; Cell Line; Cell Survival; Cytomegalovirus; Dichlororibofuranosylbenzimidazole; Drug Design; Fibroblasts; Herpesvirus 1, Human; Humans; KB Cells; Structure-Activity Relationship

1994
Rat multispecific organic anion transporter 1 (rOAT1) transports zidovudine, acyclovir, and other antiviral nucleoside analogs.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:3

    Topics: Acyclovir; Animals; Anion Transport Proteins; Antiviral Agents; Carrier Proteins; Didanosine; In Vitro Techniques; Lamivudine; Oocytes; Rats; Stavudine; Transfection; Trifluridine; Xenopus laevis; Zalcitabine; Zidovudine

2000
Exploring the role of different drug transport routes in permeability screening.
    Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2

    Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics

2005
Inhibition of herpes simplex virus thymidine kinases by 2-phenylamino-6-oxopurines and related compounds: structure-activity relationships and antiherpetic activity in vivo.
    Journal of medicinal chemistry, 2005, Jun-02, Volume: 48, Issue:11

    Topics: Animals; Antiviral Agents; Cloning, Molecular; Encephalitis, Herpes Simplex; Eye Infections, Viral; Guanine; Herpesvirus 1, Human; Herpesvirus 2, Human; Mice; Phosphorylation; Purinones; Recombinant Proteins; Structure-Activity Relationship; Thymidine Kinase; Virus Activation

2005
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerases.
    Journal of medicinal chemistry, 2005, Sep-08, Volume: 48, Issue:18

    Topics: Animals; Antiviral Agents; Cell Line; Cell Survival; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Point Mutation; Pyridines; Pyridones; Structure-Activity Relationship; Thiophenes; Viral Plaque Assay; Viral Proteins

2005
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
2-Aryl-2-hydroxyethylamine substituted 4-oxo-4,7-dihydrothieno[2,3-b]pyridines as broad-spectrum inhibitors of human herpesvirus polymerases.
    Bioorganic & medicinal chemistry letters, 2007, Jun-15, Volume: 17, Issue:12

    Topics: Antiviral Agents; Binding, Competitive; Cytomegalovirus; DNA-Directed DNA Polymerase; Enzyme Inhibitors; Ethylamines; Exodeoxyribonucleases; Herpes Zoster; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 4, Human; Humans; Models, Chemical; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship; Viral Proteins

2007
Sensitivity of monkey B virus (Cercopithecine herpesvirus 1) to antiviral drugs: role of thymidine kinase in antiviral activities of substrate analogs and acyclonucleosides.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:6

    Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Chlorocebus aethiops; Deoxyuridine; Enzyme Inhibitors; Guanine; Herpesvirus 1, Cercopithecine; Microbial Sensitivity Tests; Molecular Sequence Data; Nucleosides; Phosphorylation; Substrate Specificity; Thymidine; Thymidine Kinase; Vero Cells

2007
7-Oxo-4,7-dihydrothieno[3,2-b]pyridine-6-carboxamides: synthesis and biological activity of a new class of highly potent inhibitors of human cytomegalovirus DNA polymerase.
    Bioorganic & medicinal chemistry letters, 2007, Jul-15, Volume: 17, Issue:14

    Topics: Cytomegalovirus; Enzyme Inhibitors; Nucleic Acid Synthesis Inhibitors; Pyridines; Structure-Activity Relationship

2007
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibition.
    Bioorganic & medicinal chemistry letters, 2008, Jul-15, Volume: 18, Issue:14

    Topics: Antiviral Agents; Chemistry, Pharmaceutical; Cytomegalovirus; Drug Design; Enzyme Inhibitors; Esters; Furans; Herpesviridae; Herpesvirus 3, Human; Herpesvirus 4, Human; Inhibitory Concentration 50; Models, Chemical; Molecular Conformation; Nucleic Acid Synthesis Inhibitors; Pyridones; Simplexvirus

2008
4"-Benzoylureido-TSAO derivatives as potent and selective non-nucleoside HCMV inhibitors. Structure-activity relationship and mechanism of antiviral action.
    Journal of medicinal chemistry, 2008, Sep-25, Volume: 51, Issue:18

    Topics: Antiviral Agents; Cell Line; Cytomegalovirus; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Thymidine; Urea

2008
Synthesis and in vitro activities of a new antiviral duplex drug linking Zidovudine (AZT) and Foscarnet (PFA) via an octadecylglycerol residue.
    Bioorganic & medicinal chemistry, 2009, Jan-01, Volume: 17, Issue:1

    Topics: Antiviral Agents; Cross-Linking Reagents; Cytomegalovirus; Drug Interactions; Foscarnet; Glyceryl Ethers; HIV; Humans; Inhibitory Concentration 50; Simplexvirus; Zidovudine

2009
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
    Bioorganic & medicinal chemistry, 2009, Jan-15, Volume: 17, Issue:2

    Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship

2009
4-Benzyloxy-gamma-sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus.
    Journal of medicinal chemistry, 2009, Mar-26, Volume: 52, Issue:6

    Topics: Animals; Antiviral Agents; Cell Line; Chlorocebus aethiops; Cytomegalovirus; Herpesvirus 3, Human; Humans; Magnetic Resonance Spectroscopy; Microbial Sensitivity Tests; Naphthalenesulfonates; Spectrometry, Mass, Electrospray Ionization; Structure-Activity Relationship; Virus Replication

2009
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Inhibition of herpesvirus replication by 5-substituted 4'-thiopyrimidine nucleosides.
    Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:12

    Topics: Animals; Antiviral Agents; Cell Line; Cell Proliferation; Cells, Cultured; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Fluorescent Antibody Technique, Indirect; Herpesviridae; Herpesviridae Infections; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Molecular Structure; Pyrimidine Nucleosides; Viral Proteins; Virus Replication

2009
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
    Journal of medicinal chemistry, 2010, Feb-11, Volume: 53, Issue:3

    Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations

2010
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymerase.
    Bioorganic & medicinal chemistry letters, 2010, Mar-15, Volume: 20, Issue:6

    Topics: Antiviral Agents; Drug Design; Protease Inhibitors; Quinoxalines; Serine Endopeptidases

2010
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubility.
    Bioorganic & medicinal chemistry letters, 2010, May-15, Volume: 20, Issue:10

    Topics: Antiviral Agents; Cytomegalovirus; DNA-Directed DNA Polymerase; Herpesviridae; Herpesvirus 1, Human; Herpesvirus 3, Human; Humans; Nucleic Acid Synthesis Inhibitors; Pyrroles; Quinolines; Solubility; Structure-Activity Relationship

2010
Genotypic characterization of UL23 thymidine kinase and UL30 DNA polymerase of clinical isolates of herpes simplex virus: natural polymorphism and mutations associated with resistance to antivirals.
    Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:11

    Topics: Adolescent; Adult; Aged; Antiviral Agents; Child; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Female; Genotype; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Male; Middle Aged; Molecular Sequence Data; Mutation; Polymorphism, Genetic; Thymidine Kinase; Viral Proteins; Young Adult

2010
A point mutation within a distinct conserved region of the herpes simplex virus DNA polymerase gene confers drug resistance.
    Journal of virology, 1992, Volume: 66, Issue:3

    Topics: Acyclovir; Amino Acid Sequence; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Genes, Viral; Molecular Sequence Data; Mutation; Phosphonoacetic Acid; Sequence Alignment; Simplexvirus; Tyrosine; Viral Structural Proteins

1992
[Acyclovir-resistant herpes simplex virus infections in immunocompromised patients].
    Nederlands tijdschrift voor geneeskunde, 1992, Feb-08, Volume: 136, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Bone Transplantation; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Retrospective Studies; Simplexvirus

1992
Clinical effects and in vitro studies of trifluorothymidine combined with interferon-alpha for treatment of drug-resistant and -sensitive herpes simplex virus infections.
    The Journal of infectious diseases, 1992, Volume: 166, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Combined Modality Therapy; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Interferon Type I; Male; Phosphonoacetic Acid; Recombinant Proteins; Recurrence; Simplexvirus; Trifluridine; Virus Replication

1992
Heterogeneity of a herpes simplex virus clinical isolate exhibiting resistance to acyclovir and foscarnet.
    Advances in experimental medicine and biology, 1992, Volume: 312

    Topics: Acyclovir; Animals; Drug Resistance, Microbial; Foscarnet; Genetic Variation; Herpes Simplex; Humans; Phosphonoacetic Acid; Simplexvirus

1992
Acyclovir-resistant herpes simplex virus keratouveitis after penetrating keratoplasty.
    Ophthalmology, 1992, Volume: 99, Issue:12

    Topics: Acyclovir; Administration, Oral; Animals; Drug Resistance, Microbial; Foscarnet; Humans; Keratitis, Herpetic; Keratoplasty, Penetrating; Male; Microbial Sensitivity Tests; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Simplexvirus; Uveitis; Vero Cells; Visual Acuity

1992
[Development of resistance of herpes simplex virus to antivirus drugs in vitro].
    Yao xue xue bao = Acta pharmaceutica Sinica, 1992, Volume: 27, Issue:1

    Topics: Acyclovir; Ancitabine; Animals; Antiviral Agents; Drug Combinations; Drug Resistance, Microbial; Foscarnet; Phosphonoacetic Acid; Simplexvirus; Vero Cells

1992
[Type 1 herpesvirus cutaneo-mucous infection resistant to aciclovir in a HIV infected patient. Clinical and virological study].
    Annales de medecine interne, 1992, Volume: 143, Issue:3

    Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; HIV Infections; Humans; Male; Opportunistic Infections; Phosphonoacetic Acid; Skin Diseases

1992
[Resistance of viruses to antiviral agents].
    Presse medicale (Paris, France : 1983), 1992, Mar-28, Volume: 21, Issue:12

    Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Humans; Immunocompromised Host; Phosphonoacetic Acid; Rimantadine; Virus Diseases; Zidovudine

1992
Foscarnet therapy in five patients with AIDS and acyclovir-resistant varicella-zoster virus infection.
    Annals of internal medicine, 1991, Jul-01, Volume: 115, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cohort Studies; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Middle Aged; Phosphonoacetic Acid; Skin Diseases, Infectious

1991
Acyclovir-resistant varicella zoster responsive to foscarnet.
    Archives of dermatology, 1991, Volume: 127, Issue:7

    Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; HIV Infections; Humans; Male; Phosphonoacetic Acid; Skin Diseases, Infectious

1991
Sensitive, reproducible and convenient fluorometric assay for the in vitro evaluation of anti-cytomegalovirus agents.
    Journal of virological methods, 1991, Volume: 35, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Esterases; Flow Cytometry; Fluoresceins; Fluorometry; Foscarnet; Ganciclovir; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid; Polyethylene Glycols; Suramin

1991
CMV retinitis and the use of FK 506.
    Transplantation proceedings, 1991, Volume: 23, Issue:6

    Topics: Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Humans; Immunosuppression Therapy; Phosphonoacetic Acid; Retinitis; Retrospective Studies; Tacrolimus; Transplantation Immunology

1991
Interference of antiviral substances with replication of hepatitis delta virus RNA in primary woodchuck hepatocytes.
    Progress in clinical and biological research, 1991, Volume: 364

    Topics: Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Foscarnet; Hepatitis Delta Virus; Liver; Marmota; Phosphonoacetic Acid; Ribavirin; RNA, Viral; Virus Replication

1991
[Chronic erosive, therapy-resistant perianal herpes (type II) with herpes proctitis in AIDS].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1991, Volume: 42, Issue:2

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Foscarnet; Herpes Genitalis; Humans; Infusions, Intravenous; Male; Opportunistic Infections; Phosphonoacetic Acid; Proctitis

1991
Herpes simplex virus type-2 ulcers resistant to acyclovir in an AIDS patient--successful treatment with foscarnet.
    Klinische Wochenschrift, 1991, Apr-04, Volume: 69, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Anus Diseases; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid

1991
Acyclovir resistance/susceptibility in herpes simplex virus type 2 sequential isolates from an AIDS patient.
    Journal of acquired immune deficiency syndromes, 1991, Volume: 4, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV-2; Humans; Male; Microbial Sensitivity Tests; Phosphonoacetic Acid

1991
Foscarnet effective in acyclovir-resistant herpes.
    American pharmacy, 1991, Volume: NS31, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Injections, Intravenous; Phosphonoacetic Acid; Recurrence; Vidarabine

1991
Postexposure treatment of experimental DHBV infection: a new therapeutic strategy.
    Journal of medical virology, 1990, Volume: 30, Issue:4

    Topics: Acyclovir; Animals; Antiviral Agents; DNA, Viral; Ducks; Female; Foscarnet; Hepatitis B Virus, Duck; Hepatitis, Viral, Animal; Male; Phosphonoacetic Acid

1990
[Aciclovir-resistant herpes simplex virus infection in an immuno-depressed patient. Favourable effect of foscarnet].
    Presse medicale (Paris, France : 1983), 1990, Dec-01, Volume: 19, Issue:41

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; HIV Seropositivity; Homosexuality; Humans; Male; Phosphonoacetic Acid

1990
Foscarnet therapy for acyclovir-resistant mucocutaneous herpes simplex virus infection in 26 AIDS patients: preliminary data.
    The Journal of infectious diseases, 1990, Volume: 161, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Male; Phosphonoacetic Acid; Risk Factors; Simplexvirus; Vidarabine

1990
Ocular herpes simplex virus infections: reduced sensitivity to acyclovir in primary disease.
    The British journal of ophthalmology, 1990, Volume: 74, Issue:5

    Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Humans; Idoxuridine; Keratitis, Dendritic; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine

1990
Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation.
    The Journal of infectious diseases, 1990, Volume: 162, Issue:1

    Topics: Acyclovir; Adult; Animals; Antiviral Agents; Bone Marrow Transplantation; Cells, Cultured; Drug Resistance, Microbial; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Herpes Simplex; Humans; Male; Middle Aged; Phosphonoacetic Acid; Pneumonia, Viral; Simplexvirus; Thymidine Kinase; Vero Cells; Vidarabine

1990
Altered sensitivity to antiviral drugs of herpes simplex virus isolates from a patient with the acquired immunodeficiency syndrome.
    The Journal of infectious diseases, 1990, Volume: 162, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Aphidicolin; Deoxyguanosine; Diterpenes; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Humans; Phosphonoacetic Acid; Simplexvirus

1990
Foscarnet therapy for severe acyclovir-resistant herpes simplex virus type-2 infections in patients with the acquired immunodeficiency syndrome (AIDS). An uncontrolled trial.
    Annals of internal medicine, 1989, May-01, Volume: 110, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Organophosphorus Compounds; Phosphonoacetic Acid

1989
Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type 2 lesion in a patient with AIDS.
    Oral surgery, oral medicine, and oral pathology, 1989, Volume: 67, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Candidiasis, Oral; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Stomatitis, Herpetic

1989
Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome.
    The New England journal of medicine, 1989, Feb-02, Volume: 320, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Herpes Simplex; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases, Infectious

1989
[Chemotherapy of cytomegalovirus infections].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2

    Topics: Acyclovir; Adenine; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid

1989
[Diagnosis and treatment of cytomegalovirus infections].
    Nihon rinsho. Japanese journal of clinical medicine, 1989, Volume: 47, Issue:2

    Topics: Acyclovir; Antigens, Viral; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Foscarnet; Ganciclovir; Humans; Infant, Newborn; Phosphonoacetic Acid; Pregnancy; Serologic Tests

1989
Susceptibility of human herpesvirus 6 to acyclovir and ganciclovir.
    Lancet (London, England), 1989, Sep-09, Volume: 2, Issue:8663

    Topics: Acyclovir; Antiviral Agents; Foscarnet; Ganciclovir; Herpesviridae; Humans; Microbial Sensitivity Tests; Phosphonoacetic Acid

1989
Treatment of CMV retinitis in an AIDS patient.
    The British journal of ophthalmology, 1987, Volume: 71, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Cytomegalovirus Infections; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Male; Middle Aged; Phosphonoacetic Acid; Retina; Retinitis; Visual Acuity

1987
Aerosol administration of antiviral agents to treat lung infection due to murine cytomegalovirus.
    The Journal of infectious diseases, 1988, Volume: 157, Issue:2

    Topics: Acyclovir; Administration, Oral; Aerosols; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Female; Foscarnet; Ganciclovir; Mice; Mice, Inbred BALB C; Phosphonoacetic Acid; Pneumonia, Viral; Pregnancy; Pregnancy Complications, Infectious; Ribavirin

1988
Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
    The Journal of general virology, 1988, Volume: 69 ( Pt 6)

    Topics: Acyclovir; Administration, Oral; Administration, Topical; Animals; Antiviral Agents; Disease Models, Animal; DNA Replication; DNA, Viral; Foscarnet; Herpes Simplex; Male; Mice; Nervous System Diseases; Organophosphorus Compounds; Phosphonoacetic Acid; Recurrence; Simplexvirus; Skin; Skin Diseases, Infectious; Virus Replication

1988
Failure of antiviral therapy for acquired immunodeficiency syndrome-related cytomegalovirus myelitis.
    Archives of neurology, 1988, Volume: 45, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cytomegalovirus Infections; Encephalomyelitis; Foscarnet; Ganciclovir; Humans; Male; Organophosphorus Compounds; Phosphonoacetic Acid

1988
Antiherpesvirus activity and mechanism of action of indolo-(2,3-b)quinoxaline and analogs.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:11

    Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Cytomegalovirus; DNA-Directed DNA Polymerase; DNA, Viral; Drug Evaluation, Preclinical; Foscarnet; Herpesvirus 3, Human; Humans; Indoles; Nucleic Acid Hybridization; Phosphonoacetic Acid; Quinoxalines; Simplexvirus; Structure-Activity Relationship; Tumor Cells, Cultured; Virus Replication

1988
Efficacy of 5-vinyl-1-beta-D-arabinofuranosyluracil (VaraU) against herpes simplex virus type 2 strains in cell cultures and against experimental herpes encephalitis in mice: comparison with acyclovir and foscarnet.
    Pharmaceutical research, 1987, Volume: 4, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Uridine; Virus Replication

1987
Sensitivity of HSV clinical isolates to foscarnet and in vitro dual combination of foscarnet and acyclovir.
    Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl

    Topics: Acyclovir; Antiviral Agents; Drug Interactions; Foscarnet; Herpes Labialis; Humans; Microbial Sensitivity Tests; Neutral Red; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay

1987
Acyclovir-resistant herpes in AIDS treated with foscarnet.
    Lancet (London, England), 1988, Aug-06, Volume: 2, Issue:8606

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Thymidine; Zidovudine

1988
Herpes simplex type 1 defective interfering particles do not affect the antiviral activity of acyclovir, foscarnet and adenine arabinoside.
    Acta virologica, 1988, Volume: 32, Issue:2

    Topics: Acyclovir; Animals; Defective Viruses; Foscarnet; Organophosphorus Compounds; Phosphonoacetic Acid; Serial Passage; Simplexvirus; Vidarabine

1988
In vitro effect of acyclovir and other antiherpetic compounds on the replication of channel catfish virus.
    Antiviral research, 1985, Volume: 5, Issue:5

    Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; DNA Replication; Fishes; Foscarnet; Herpesviridae; Kinetics; Phosphonoacetic Acid; Vidarabine; Viral Plaque Assay; Virus Replication

1985
Comparison of foscarnet cream, acyclovir cream, and acyclovir ointment in the topical treatment of experimental cutaneous herpes simplex virus type 1 infection.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:1

    Topics: Acyclovir; Administration, Topical; Animals; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Ointments; Organophosphorus Compounds; Phosphonoacetic Acid

1986
Screening of antiviral drugs for treatment of hepatitis B.
    Journal of hepatology, 1986, Volume: 3 Suppl 2

    Topics: Acyclovir; Animals; Antiviral Agents; Drug Evaluation, Preclinical; Ducks; Foscarnet; Hepatitis B; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Suramin

1986
Chronic herpetic infection in an immunocompromised patient: report of a case.
    Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 1987, Volume: 45, Issue:8

    Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Chronic Disease; Foscarnet; Humans; Immunosuppression Therapy; Leukemia, Lymphoid; Male; Middle Aged; Phosphonoacetic Acid; Stomatitis, Herpetic; Vidarabine

1987
Synergistic inhibition of anatid herpesvirus replication by acyclovir and phosphonocompounds.
    Intervirology, 1987, Volume: 28, Issue:2

    Topics: Acyclovir; Animals; Deoxycytidine; Drug Interactions; Drug Resistance, Microbial; Foscarnet; Herpesviridae; Mutation; Organophosphorus Compounds; Phosphonoacetic Acid; Thymidine; Virus Replication

1987
In vitro inhibition of human herpesvirus-6 by phosphonoformate.
    Journal of virological methods, 1988, Volume: 21, Issue:1-4

    Topics: Acyclovir; Antiviral Agents; Cell Line; Foscarnet; Ganciclovir; Herpesviridae; Humans; Organophosphorus Compounds; Phosphonoacetic Acid

1988
Sensitivity of arabinosyladenine-resistant mutants of herpes simplex virus to other antiviral drugs and mapping of drug hypersensitivity mutations to the DNA polymerase locus.
    Journal of virology, 1985, Volume: 53, Issue:2

    Topics: Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Genes, Viral; Idoxuridine; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Vidarabine

1985
Antiviral activity of CP-20,961 against herpes simplex viruses in vitro.
    Intervirology, 1985, Volume: 23, Issue:1

    Topics: Acyclovir; Animals; Bromodeoxyuridine; Cells, Cultured; Diamines; Embryo, Mammalian; Foscarnet; Guinea Pigs; Phosphonoacetic Acid; Rabbits; Simplexvirus

1985
Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Antiviral research, 1985, Volume: 5, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Deoxyuridine; DNA, Viral; Drug Combinations; Drug Resistance, Microbial; Drug Synergism; Encephalitis; Foscarnet; Herpes Simplex; Male; Mice; Organophosphorus Compounds; Phosphonoacetic Acid; Rabbits; Simplexvirus; Thymidine; Trifluridine; Vidarabine; Virus Replication

1985
Mutually exclusive inhibition of herpesvirus DNA polymerase by aphidicolin, phosphonoformate, and acyclic nucleoside triphosphates.
    Antimicrobial agents and chemotherapy, 1985, Volume: 27, Issue:4

    Topics: Acyclovir; Antiviral Agents; Aphidicolin; Deoxyribonucleases; Diterpenes; Foscarnet; Guanosine Triphosphate; Kinetics; Nucleic Acid Synthesis Inhibitors; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus

1985
Multiplicity dependence and sensitivity of herpes simplex virus isolates to antiviral compounds.
    The Journal of antimicrobial chemotherapy, 1985, Volume: 15, Issue:5

    Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Foscarnet; Humans; Idoxuridine; Microbial Sensitivity Tests; Phosphonoacetic Acid; Simplexvirus; Vidarabine

1985
Treatment of experimental herpes simplex virus type 1 encephalitis in mice with (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil: comparison with bromovinyl-deoxyuridine and acyclovir.
    Antiviral research, 1986, Volume: 6, Issue:2

    Topics: Acyclovir; Animals; Arabinofuranosyluracil; Bromodeoxyuridine; Cells, Cultured; Encephalitis; Female; Foscarnet; Herpes Simplex; Humans; Mice; Phosphonoacetic Acid; Simplexvirus; Uridine; Viral Plaque Assay

1986
Comparative methods for detection of thymidine kinase-deficient herpes simplex virus type 1 strains.
    Antimicrobial agents and chemotherapy, 1986, Volume: 30, Issue:4

    Topics: Acyclovir; Antiviral Agents; DNA, Viral; Enzyme-Linked Immunosorbent Assay; Foscarnet; Nucleic Acid Hybridization; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Viral Plaque Assay

1986
Anti-herpes virus combinations in relation to drug resistance.
    The Journal of antimicrobial chemotherapy, 1986, Volume: 18 Suppl B

    Topics: Acyclovir; Adenosine Deaminase Inhibitors; Animals; Antiviral Agents; Diphosphates; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Foscarnet; Herpes Simplex; In Vitro Techniques; Nucleic Acid Synthesis Inhibitors; Phosphonoacetic Acid; Simplexvirus; Thymidine Kinase; Uridine Phosphorylase; Vidarabine

1986
Synthesis of cytomegalovirus DNA is an antiviral target late in virus growth.
    The Journal of general virology, 1987, Volume: 68 ( Pt 6)

    Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; DNA, Viral; Floxuridine; Foscarnet; Ganciclovir; Humans; Phosphonoacetic Acid; Spermidine; Spermine; Viral Proteins

1987
[Prevention and treatment of cytomegalovirus infections after graft of allogenic bone marrow].
    Nouvelle revue francaise d'hematologie, 1987, Volume: 29, Issue:1

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Infections; Foscarnet; Ganciclovir; Humans; Immunization, Passive; Phosphonoacetic Acid; Postoperative Complications

1987
Nucleoside pools of acyclovir-treated herpes simplex type 1 infected cells.
    Antiviral research, 1985, Volume: 5, Issue:2

    Topics: Acyclovir; Animals; Cells, Cultured; Chlorocebus aethiops; Foscarnet; Herpes Simplex; Humans; Kinetics; Nucleosides; Phosphonoacetic Acid; Thymidine

1985
Cutaneous herpes simplex virus infection of the guinea pig: lack of resistance to acyclovir and phosphonoformic acid after topical treatment.
    Medical microbiology and immunology, 1984, Volume: 173, Issue:4

    Topics: Acyclovir; Administration, Topical; Animals; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Male; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases, Infectious

1984
Identification of a gene function of herpes simplex virus type 1 essential for amplification of simian virus 40 DNA sequences in transformed hamster cells.
    Virology, 1984, Apr-30, Volume: 134, Issue:2

    Topics: Acyclovir; Animals; Cell Line; Cell Transformation, Viral; Centrifugation, Density Gradient; Cricetinae; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Gene Amplification; Genes, Viral; Mutation; Phosphonoacetic Acid; Simian virus 40; Simplexvirus; Temperature; Tunicamycin; Virus Replication

1984
Properties of antiviral agents. 1.
    Lancet (London, England), 1984, Sep-01, Volume: 2, Issue:8401

    Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Evaluation Studies as Topic; Foscarnet; Herpesviridae; Humans; Idoxuridine; Phosphonoacetic Acid; Trifluridine; Vidarabine; Viruses

1984
Effects of acyclovir combined with other antiviral agents on human cytomegalovirus.
    The American journal of medicine, 1982, Jul-20, Volume: 73, Issue:1A

    Topics: Acyclovir; Antiviral Agents; Cell Line; Cytomegalovirus; Drug Evaluation, Preclinical; Drug Synergism; Foscarnet; Guanine; Humans; Interferons; Mathematics; Phosphonoacetic Acid; Trifluridine; Viral Plaque Assay

1982
Combined interaction of antiherpes substances and interferon beta on the multiplication of herpes simplex virus.
    Archives of virology, 1982, Volume: 73, Issue:2

    Topics: Acyclovir; Animals; Antiviral Agents; Arabinonucleosides; Cell Line; Chlorocebus aethiops; Cytopathogenic Effect, Viral; Deoxyuridine; Drug Interactions; Foscarnet; Interferon Type I; Phosphonoacetic Acid; Simplexvirus; Tegafur; Thymidine; Vidarabine Phosphate

1982
Combined chemotherapy of cutaneous herpes simplex infection of the guinea pig.
    Journal of medical virology, 1983, Volume: 12, Issue:2

    Topics: Acyclovir; Animals; Antiviral Agents; Arabinonucleosides; Deoxyuridine; Drug Therapy, Combination; Female; Foscarnet; Guinea Pigs; Herpes Simplex; Idoxuridine; Male; Phosphonoacetic Acid; Skin Diseases, Infectious; Thymidine; Trifluridine; Vidarabine Phosphate

1983
Effect of eight antiviral drugs on the reactivation of herpes simplex virus in explant cultures of latently infected mouse trigeminal ganglia.
    The Journal of investigative dermatology, 1984, Volume: 83, Issue:5

    Topics: Acyclovir; Animals; Antibodies, Viral; Antiviral Agents; Arabinofuranosyluracil; Arabinonucleosides; Bromodeoxyuridine; Culture Media; Culture Techniques; Cytarabine; Foscarnet; Mice; Mice, Hairless; Neutralization Tests; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trigeminal Nerve; Vidarabine Phosphate; Virus Activation

1984
Neuritic uptake and transport of antiviral drugs modifying herpes simplex virus infection of rat sensory neurons.
    Archives of virology, 1984, Volume: 81, Issue:3-4

    Topics: Acyclovir; Animals; Antigens, Viral; Biological Transport; Cells, Cultured; Female; Foscarnet; Ganglia, Spinal; Herpes Simplex; Nervous System Diseases; Neurons; Organophosphorus Compounds; Phosphonoacetic Acid; Pregnancy; Rats; Rats, Inbred Strains; Vidarabine; Virus Replication

1984
Treatment of primary acute genital herpes in guinea pigs by intraperitoneal administration of fluoropyrimidines.
    Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Arabinofuranosyluracil; Cytarabine; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Injections, Intraperitoneal; Male; Phosphonoacetic Acid; Uridine; Virus Replication

1984
The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    The Journal of infectious diseases, 1981, Volume: 143, Issue:2

    Topics: Acyclovir; Antiviral Agents; Arabinonucleosides; Bromodeoxyuridine; Drug Resistance, Microbial; Foscarnet; Guanine; Microbial Sensitivity Tests; Mutation; Phosphonoacetic Acid; Simplexvirus; Thymidine; Trifluridine; Vidarabine

1981
Persistent reactivable latent herpes simplex virus infection in trigeminal ganglia of mice treated with antiviral drugs.
    Archives of virology, 1981, Volume: 69, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Foscarnet; Guanine; Herpes Simplex; Idoxuridine; Male; Mice; Mice, Inbred Strains; Phosphonoacetic Acid; Simplexvirus; Trigeminal Ganglion; Trigeminal Nerve; Vidarabine; Virus Replication

1981
Chemotherapy of influenza and herpes virus infections.
    Journal of the Royal College of Physicians of London, 1981, Volume: 15, Issue:4

    Topics: Acyclovir; Amantadine; Antiviral Agents; Bromodeoxyuridine; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Phosphonoacetic Acid; Vidarabine

1981
Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
    The Journal of infectious diseases, 1982, Volume: 145, Issue:4

    Topics: Acyclovir; Administration, Topical; Animals; Dose-Response Relationship, Drug; Foscarnet; Guanine; Guinea Pigs; Herpes Simplex; Ointments; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Skin Diseases

1982
Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    The American journal of medicine, 1982, Jul-20, Volume: 73, Issue:1A

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chlorocebus aethiops; Drug Evaluation, Preclinical; Drug Interactions; Drug Synergism; Foscarnet; Guanine; Phosphonoacetic Acid; Simplexvirus; Trifluridine; Vidarabine

1982
Synergism among BIOLF-62, phosphonoformate, and other antiherpetic compounds.
    Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:6

    Topics: Acyclovir; Antiviral Agents; Cells, Cultured; Drug Synergism; Foscarnet; Ganciclovir; Humans; Organophosphorus Compounds; Phosphonoacetic Acid; Simplexvirus; Viral Plaque Assay

1982
Inhibition of human cytomegalovirus by trifluorothymidine.
    Antimicrobial agents and chemotherapy, 1983, Volume: 23, Issue:1

    Topics: Acyclovir; Cytomegalovirus; Foscarnet; Humans; Interferon Type I; Lung; Phosphonoacetic Acid; Thymidine; Trifluridine; Virus Replication

1983
Effect of acyclovir and phosphonoformate on cytomegalovirus infection in guinea pigs.
    Intervirology, 1984, Volume: 21, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus Infections; Disease Models, Animal; Foscarnet; Guinea Pigs; Infectious Mononucleosis; Liver; Lung; Organophosphorus Compounds; Phosphonoacetic Acid; Spleen

1984
Synergistic antiviral effects of antiherpes compounds and human leukocyte interferon on varicella-zoster virus in vitro.
    Antimicrobial agents and chemotherapy, 1984, Volume: 25, Issue:4

    Topics: Acyclovir; Antiviral Agents; Bromodeoxyuridine; Drug Synergism; Foscarnet; Herpesvirus 3, Human; Humans; Interferon Type I; Microbial Sensitivity Tests; Phosphonoacetic Acid; Vidarabine

1984
Suppression of infectious virus spread to the liver by foscarnet following lethal infection of acyclovir-resistant herpes simplex virus type 2 in mice.
    Antiviral research, 1995, Volume: 27, Issue:1-2

    Topics: Acyclovir; Animals; Arabinonucleosides; Brain; Chlorocebus aethiops; Drug Resistance, Microbial; Foscarnet; Hepatitis, Viral, Animal; Herpes Genitalis; Herpesvirus 2, Human; Humans; Injections, Intraperitoneal; Lethal Dose 50; Mice; Mice, Inbred C3H; Phosphonoacetic Acid; Thymidine; Vero Cells; Vidarabine

1995
Antiviral susceptibility testing with a cell line which expresses beta-galactosidase after infection with herpes simplex virus.
    Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:6

    Topics: Acyclovir; Animals; beta-Galactosidase; Cell Line, Transformed; Chlorocebus aethiops; DNA Replication; Foscarnet; Humans; Simplexvirus; Vero Cells; Viral Plaque Assay

1995
[Chronic herpes resistant to acyclovir in a patient with AIDS].
    Annales de dermatologie et de venereologie, 1994, Volume: 121, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Buttocks; Chronic Disease; Drug Resistance; Foscarnet; Herpesviridae Infections; Humans; Male; Skin Diseases, Viral

1994
Can antiviral agents decrease the occurrence of Kaposi's sarcoma? Clinical Epidemiology Group from Centres d'Information et de Soins de l'Immunodéficience Humaine.
    Lancet (London, England), 1995, Aug-26, Volume: 346, Issue:8974

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Bias; Female; Follow-Up Studies; Foscarnet; Ganciclovir; HIV Seropositivity; Humans; Information Systems; Male; Proportional Hazards Models; Risk Factors; Sarcoma, Kaposi

1995
Antiviral activities of nucleosides and nucleotides against wild-type and drug-resistant strains of murine cytomegalovirus.
    Antiviral research, 1995, Volume: 26, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Guanine; Herpesviridae Infections; Mice; Mice, SCID; Microbial Sensitivity Tests; Muromegalovirus; Nucleosides; Nucleotides; Organophosphonates; Organophosphorus Compounds

1995
Disseminated acyclovir-resistant herpes simplex virus type 2 treated successfully with foscarnet.
    The Journal of infectious diseases, 1995, Volume: 171, Issue:2

    Topics: Acyclovir; Adult; Drug Resistance, Microbial; Foscarnet; Hand; Herpes Simplex; Herpesvirus 2, Human; Humans; Male

1995
AIDS-associated Kaposi's sarcoma.
    Science (New York, N.Y.), 1995, Feb-24, Volume: 267, Issue:5201

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; AIDS-Related Opportunistic Infections; Female; Foscarnet; Ganciclovir; Herpesviridae Infections; Humans; Male; Retrospective Studies; Risk Factors; Sarcoma, Kaposi

1995
Successful treatment of progressive mucocutaneous infection due to acyclovir- and foscarnet-resistant herpes simplex virus with (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine (HPMPC).
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1994, Volume: 18, Issue:4

    Topics: Acyclovir; Administration, Topical; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; DNA Restriction Enzymes; DNA, Viral; Drug Resistance, Microbial; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Opportunistic Infections; Organophosphonates; Organophosphorus Compounds; Skin Diseases, Viral; Thymidine Kinase

1994
Correlation between response to acyclovir and foscarnet therapy and in vitro susceptibility result for isolates of herpes simplex virus from human immunodeficiency virus-infected patients.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:6

    Topics: Acyclovir; Female; Foscarnet; Herpes Simplex; HIV Infections; Humans; Male; Microbial Sensitivity Tests; Simplexvirus

1994
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1994, Apr-01, Volume: 36, Issue:919

    Topics: Acyclovir; Amantadine; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Interferon-alpha; Ribavirin; Rimantadine; Virus Diseases

1994
[Resistance to virostatic agents in Herpes viruses: mechanism, incidence and clinical significance].
    Schweizerische medizinische Wochenschrift, 1994, Jan-29, Volume: 124, Issue:4

    Topics: Acyclovir; Antiviral Agents; Drug Resistance; Foscarnet; Ganciclovir; Herpesviridae; Humans; Immunocompetence; Immunocompromised Host; Phosphorylation

1994
A rapid screen test for in vitro susceptibility of clinical herpes simplex virus isolates.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:4

    Topics: Acyclovir; Animals; Drug Resistance, Microbial; Evaluation Studies as Topic; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Neutralization Tests; Sensitivity and Specificity; Time Factors; Vero Cells

1994
Retinal detachment in patients with acquired immunodeficiency syndrome.
    German journal of ophthalmology, 1994, Volume: 3, Issue:1

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Cytomegalovirus Retinitis; Follow-Up Studies; Foscarnet; Ganciclovir; Humans; Incidence; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Visual Acuity

1994
Acyclovir-resistant neonatal herpes simplex virus infection of the larynx.
    The Journal of pediatrics, 1994, Volume: 124, Issue:6

    Topics: Acyclovir; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; Humans; Infant, Newborn; Laryngeal Diseases

1994
In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:10

    Topics: Acyclovir; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Guanine; Half-Life; Humans; Microbial Sensitivity Tests; Mutation; Simplexvirus; Thymidine Kinase

1993
Foscarnet-resistant herpes simplex virus infection in patients with AIDS.
    The Journal of infectious diseases, 1994, Volume: 169, Issue:1

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Foscarnet; Ganciclovir; Herpes Genitalis; Herpes Labialis; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Vidarabine

1994
[Acyclovir-resistant Herpes simplex viruses in HIV-infected patients].
    Schweizerische medizinische Wochenschrift, 1993, Dec-28, Volume: 123, Issue:51-52

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Drug Resistance, Microbial; Female; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Male; Middle Aged; Stomatitis, Herpetic; Vidarabine

1993
Recurrence of presumed varicella-zoster virus retinopathy in patients with acquired immunodeficiency syndrome.
    American journal of ophthalmology, 1993, Jul-15, Volume: 116, Issue:1

    Topics: Acyclovir; Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Foscarnet; Fundus Oculi; Herpes Zoster Ophthalmicus; Humans; Injections, Intravenous; Male; Recurrence; Retinal Diseases

1993
Successful foscarnet therapy for acyclovir-resistant mucocutaneous infection with herpes simplex virus in a recipient of allogeneic BMT.
    Bone marrow transplantation, 1993, Volume: 11, Issue:2

    Topics: Acyclovir; Adult; Animals; Bone Marrow Transplantation; Chlorocebus aethiops; Esophagitis; Foscarnet; Herpes Simplex; Humans; Male; Recurrence; Simplexvirus; Transplantation, Homologous; Vero Cells

1993
Potent inhibition of Epstein-Barr virus by phosphorothioate oligodeoxynucleotides without sequence specification.
    Antimicrobial agents and chemotherapy, 1993, Volume: 37, Issue:7

    Topics: Acyclovir; Antiviral Agents; Base Sequence; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Oligodeoxyribonucleotides; Oligonucleotides, Antisense; Organophosphorus Compounds; Time Factors

1993
Foscarnet-resistant multidermatomal zoster in a patient with AIDS.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:5

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans

1995
Prognosis and response to therapy of cytomegalovirus encephalitis and meningomyelitis in AIDS.
    Neurology, 1996, Volume: 46, Issue:2

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Base Sequence; Cerebrospinal Fluid; Cytomegalovirus; Cytomegalovirus Infections; DNA Primers; Encephalitis; Foscarnet; Ganciclovir; Genes, Immediate-Early; HIV Seropositivity; Humans; Male; Meningitis; Molecular Sequence Data; Polymerase Chain Reaction; Prognosis; Sensitivity and Specificity; Spinal Cord Diseases

1996
Serous retinal detachments in a patient with clinically resistant cytomegalovirus retinitis.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1996, Volume: 114, Issue:7

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; Drug Resistance, Microbial; Drug Therapy, Combination; Exudates and Transudates; Foscarnet; Fundus Oculi; Ganciclovir; Humans; Infusions, Intravenous; Male; Recurrence; Retinal Detachment; Visual Acuity

1996
Chronic ulcerating acyclovir-resistant varicella zoster lesions in an AIDS patient.
    Scandinavian journal of infectious diseases, 1995, Volume: 27, Issue:6

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Female; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Skin Ulcer

1995
European survey of herpesvirus resistance to antiviral drugs in bone marrow transplant recipients. Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
    Bone marrow transplantation, 1996, Volume: 17, Issue:5

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Data Collection; Drug Resistance, Microbial; Europe; Foscarnet; Ganciclovir; Herpesviridae; Herpesviridae Infections; Herpesvirus 3, Human; Humans; Simplexvirus; Surveys and Questionnaires; Vidarabine

1996
Foscarnet therapy for acyclovir-resistant herpes simplex virus 1 infection in allogeneic bone marrow transplant recipients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1995, Volume: 21, Issue:6

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Reverse Transcriptase Inhibitors; Transplantation, Homologous

1995
Chronic varicella presenting as disseminated pinpoint-sized papules in a man infected with the human immunodeficiency virus.
    Dermatology (Basel, Switzerland), 1996, Volume: 192, Issue:1

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Chickenpox; Chronic Disease; Fatal Outcome; Foscarnet; Humans; Male; Recurrence

1996
Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:4

    Topics: Acyclovir; Antiviral Agents; Enzyme-Linked Immunosorbent Assay; Foscarnet; Herpes Simplex; Humans; Microbial Sensitivity Tests

1996
Patterns of resistance and sensitivity to antiviral compounds of drug-resistant strains of human cytomegalovirus selected in vitro.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1996, Volume: 15, Issue:7

    Topics: Acyclovir; Adenine; Antiviral Agents; Cells, Cultured; Cidofovir; Cytarabine; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Drug Resistance, Microbial; Fibroblasts; Foscarnet; Humans; Lung; Organophosphonates; Organophosphorus Compounds; Phosphonoacetic Acid

1996
Successful foscarnet therapy for mucocutaneous infection with herpes simplex virus in a recipient after unrelated bone marrow transplantation.
    Bone marrow transplantation, 1996, Volume: 18, Issue:6

    Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Microbial; Foscarnet; Herpes Labialis; Humans; Leukemia, Myeloid, Accelerated Phase; Male; Neutropenia; Simplexvirus; Stomatitis, Herpetic; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Whole-Body Irradiation

1996
Successful treatment of progressive outer retinal necrosis syndrome.
    Retina (Philadelphia, Pa.), 1996, Volume: 16, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Fundus Oculi; Ganciclovir; Herpes Zoster; Herpes Zoster Ophthalmicus; Humans; Infusions, Intravenous; Male; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Silicone Oils; Visual Acuity; Vitrectomy

1996
Topical foscarnet for aciclovir-resistant mucocutaneous herpes infections in AIDS.
    AIDS (London, England), 1997, Volume: 11, Issue:2

    Topics: Acyclovir; Administration, Topical; Antiviral Agents; Chickenpox; Drug Resistance, Microbial; Foscarnet; Herpes Simplex; Herpesvirus 3, Human; Humans; Simplexvirus

1997
Management of varicella zoster virus retinitis in AIDS.
    The British journal of ophthalmology, 1997, Volume: 81, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Eye Infections, Viral; Female; Foscarnet; Ganciclovir; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Detachment; Retinitis; Retrospective Studies; Treatment Outcome; Visual Acuity

1997
Sensitivity of Kaposi's sarcoma-associated herpesvirus replication to antiviral drugs. Implications for potential therapy.
    The Journal of clinical investigation, 1997, May-01, Volume: 99, Issue:9

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA Probes; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; HIV Protease Inhibitors; Humans; Methylurea Compounds; Nucleic Acid Hybridization; Organophosphonates; Organophosphorus Compounds; Phorbol Esters; Pyridines; Sarcoma, Kaposi; Tumor Cells, Cultured; Valine; Virus Replication

1997
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 1997, Aug-01, Volume: 39, Issue:1006

    Topics: 2-Aminopurine; Abnormalities, Drug-Induced; Acyclovir; Amantadine; Antiviral Agents; Cidofovir; Contraindications; Cytosine; Drug Resistance, Microbial; Eye Infections, Viral; Famciclovir; Foscarnet; Ganciclovir; Guanine; Humans; Interferon-alpha; Kidney Diseases; Lamivudine; Organophosphonates; Organophosphorus Compounds; Prodrugs; Ribavirin; Rimantadine; Trifluridine; Valacyclovir; Valine; Virus Diseases

1997
In vitro antiviral drug sensitivity of the Kaposi's sarcoma-associated herpesvirus.
    AIDS (London, England), 1997, Volume: 11, Issue:11

    Topics: Acyclovir; Antiviral Agents; Carcinogens; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; DNA, Viral; Foscarnet; Ganciclovir; Herpesvirus 8, Human; Humans; Microbial Sensitivity Tests; Organophosphonates; Organophosphorus Compounds; Phorbol 12,13-Dibutyrate; Sarcoma, Kaposi; Thymidine; Tumor Cells, Cultured; Virus Latency

1997
Herpes simplex vegetans: atypical genital herpes infection in a patient with common variable immunodeficiency.
    Journal of the American Academy of Dermatology, 1997, Volume: 37, Issue:5 Pt 2

    Topics: Acyclovir; Adult; Biopsy; Common Variable Immunodeficiency; Drug Resistance, Microbial; Female; Fetal Death; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; Humans; Infant, Newborn; Opportunistic Infections; Pregnancy; Pregnancy Complications, Infectious; Recurrence

1997
Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:12

    Topics: Acyclovir; Antiviral Agents; Fibroblasts; Flow Cytometry; Foscarnet; Ganciclovir; Herpes Simplex; Herpesvirus 1, Human; Humans; Kinetics; Microbial Sensitivity Tests; Phosphorylation; Viral Envelope Proteins

1997
Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Bone marrow transplantation, 1997, Volume: 20, Issue:12

    Topics: Acyclovir; Adolescent; Adult; Antigens, Viral; Antiviral Agents; Bone Marrow Transplantation; Cause of Death; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Female; Foscarnet; Graft vs Host Disease; Histocompatibility Testing; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukocyte Count; Life Tables; Male; Middle Aged; Neutrophils; Nuclear Family; Premedication; Prospective Studies; Recurrence; Risk; Tissue Donors; Transplantation, Homologous; Viremia

1997
Chronic vulvar ulceration in an immunocompetent woman due to acyclovir-resistant, thymidine kinase-deficient herpes simplex virus.
    The Journal of infectious diseases, 1998, Volume: 177, Issue:3

    Topics: Acyclovir; Antiviral Agents; Chronic Disease; Drug Resistance, Microbial; Female; Foscarnet; Humans; Immunocompetence; Simplexvirus; Thymidine Kinase; Ulcer; Valacyclovir; Valine; Vulvar Diseases

1998
Varicella zoster virus retrobulbar optic neuritis preceding retinitis in patients with acquired immune deficiency syndrome.
    Ophthalmology, 1998, Volume: 105, Issue:3

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cerebrospinal Fluid; Female; Foscarnet; Fundus Oculi; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Meningitis, Viral; Optic Neuritis; Orbital Diseases; Retinitis; Skin Diseases, Viral; Visual Acuity

1998
Successful treatment of an acyclovir- and foscarnet-resistant herpes simplex virus type 1 lesion with intravenous cidofovir.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 26, Issue:2

    Topics: Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Microbial; Drug Resistance, Multiple; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Organophosphonates; Organophosphorus Compounds

1998
Therapy for genital herpes in immunocompromised patients: a national survey. The Herpes Simplex Advisory Panel.
    Genitourinary medicine, 1997, Volume: 73, Issue:5

    Topics: 2-Aminopurine; Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; Drug Resistance, Microbial; Famciclovir; Foscarnet; Health Care Surveys; Herpes Genitalis; Humans; Immunocompromised Host; Recurrence

1997
Optic neuritis heralding varicella zoster virus retinitis in a patient with acquired immunodeficiency syndrome.
    Annals of neurology, 1998, Volume: 43, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Optic Neuritis; Visual Acuity

1998
The progressive outer retinal necrosis syndrome: successful treatment with combination antiviral therapy.
    Ophthalmic surgery and lasers, 1998, Volume: 29, Issue:3

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus Retinitis; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Male; Middle Aged; Recurrence; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Treatment Outcome; Visual Acuity

1998
[Acyclovir-resistance zona in a immunocompromised HIV seronegative patient].
    Annales de dermatologie et de venereologie, 1998, Volume: 125, Issue:2

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; HIV Seronegativity; Humans; Immunocompromised Host; Lymphoma, T-Cell; Male; Middle Aged

1998
Acyclovir-resistant herpes simplex virus infections in a bone marrow transplant population.
    Bone marrow transplantation, 1998, Volume: 22, Issue:6

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Child; Drug Resistance, Microbial; Female; Foscarnet; Herpesvirus 1, Human; Humans; Male; Microbial Sensitivity Tests; Stomatitis, Herpetic; Transplantation, Homologous

1998
Treatment of acyclovir-resistant, foscarnet-unresponsive HSV infection with topical cidofovir in a child with AIDS.
    Archives of dermatology, 1998, Volume: 134, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Anti-HIV Agents; Child, Preschool; Cidofovir; Cytosine; Drug Resistance, Microbial; Facial Dermatoses; Foscarnet; Herpes Simplex; Humans; Male; Organophosphonates; Organophosphorus Compounds; Treatment Failure

1998
Treatment of acyclovir-resistant herpetic ulceration with topical foscarnet and antiviral sensitivity analysis.
    Dermatology (Basel, Switzerland), 1998, Volume: 197, Issue:3

    Topics: Acyclovir; Administration, Topical; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Genital Diseases, Female; Herpes Genitalis; Herpes Simplex; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Middle Aged; Skin Ulcer

1998
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
    Transplantation, 1998, Nov-27, Volume: 66, Issue:10

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow; Bone Marrow Transplantation; Child; Child, Preschool; Cytomegalovirus Infections; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Middle Aged; Multivariate Analysis; Tissue Donors

1998
Acyclovir-resistant herpes zoster in human immunodeficiency virus-infected patients: results of foscarnet therapy.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1998, Volume: 27, Issue:6

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antiviral Agents; Drug Resistance, Microbial; Foscarnet; Herpes Zoster; HIV Infections; Humans; Retrospective Studies; Treatment Outcome

1998
Impact of cerebrospinal fluid PCR on the management of HIV-infected patients with varicella-zoster virus infection of the central nervous system.
    Journal of neurovirology, 1999, Volume: 5, Issue:2

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Central Nervous System Infections; Cytomegalovirus; DNA, Viral; Female; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; HIV Infections; Humans; Immunocompromised Host; In Situ Hybridization; Male; Middle Aged; Polymerase Chain Reaction

1999
Identification and rapid quantification of early- and late-lytic human herpesvirus 8 infection in single cells by flow cytometric analysis: characterization of antiherpesvirus agents.
    Journal of virology, 1999, Volume: 73, Issue:7

    Topics: Acyclovir; Antiviral Agents; Blotting, Western; Cell Line; Flow Cytometry; Fluorescent Antibody Technique, Indirect; Foscarnet; Glycoproteins; Herpesvirus 8, Human; Humans; Interferon-alpha; Interferon-beta; Interferon-gamma; Microscopy, Electron; Time Factors; Viral Proteins

1999
Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed.
    The Journal of infectious diseases, 1999, Volume: 180, Issue:2

    Topics: Acyclovir; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Gene Products, pol; Herpes Simplex; Humans; Microbial Sensitivity Tests; Mutation; Simplexvirus; Thymidine Kinase; Treatment Failure

1999
Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5

    Topics: Acyclovir; Antiviral Agents; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Sensitivity and Specificity; Viral Plaque Assay

1999
Foscarnet treatment of genital infection due to acyclovir-resistant herpes simplex virus type 2 in a pregnant patient with AIDS: case report.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 29, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Drug Resistance; Female; Foscarnet; Herpes Genitalis; Humans; Pregnancy; Pregnancy Complications, Infectious

1999
Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.
    Antimicrobial agents and chemotherapy, 2000, Volume: 44, Issue:1

    Topics: Acyclovir; Administration, Topical; Animals; Drug Administration Schedule; Female; Foscarnet; Herpes Simplex; Mice; Mice, Hairless; Ointments; Pharmaceutical Vehicles; Polymers; Skin Diseases, Viral; Time Factors

2000
Antiviral activity of ganciclovir elaidic acid ester against herpesviruses.
    Antiviral research, 2000, Volume: 45, Issue:3

    Topics: Acyclovir; Administration, Oral; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Cytomegalovirus; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Herpesvirus 3, Human; HIV-1; HIV-2; Humans; Mice; Simplexvirus

2000
Value of long-term administration of acyclovir and similar agents for protecting against AIDS-related lymphoma: case-control and historical cohort studies.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 30, Issue:5

    Topics: Acyclovir; Adult; Antiviral Agents; Case-Control Studies; Cohort Studies; Drug Therapy, Combination; Epstein-Barr Virus Infections; Female; Foscarnet; Ganciclovir; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Time Factors

2000
Giant cell lichenoid dermatitis within herpes zoster scars in a bone marrow recipient.
    Journal of cutaneous pathology, 2000, Volume: 27, Issue:5

    Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Cicatrix; Dermatitis; Female; Foscarnet; Giant Cells; Glucocorticoids; Graft vs Host Disease; Herpes Zoster; Humans; Lichenoid Eruptions; Precursor Cell Lymphoblastic Leukemia-Lymphoma

2000
Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy.
    Journal of acquired immune deficiency syndromes (1999), 2000, Jul-01, Volume: 24, Issue:3

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; HIV Infections; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Retrospective Studies; Risk Factors; Sarcoma, Kaposi; Skin Neoplasms

2000
Pathogenesis of acyclovir-resistant herpes simplex type 2 isolates in animal models of genital herpes: models for antiviral evaluations.
    Antiviral research, 2000, Volume: 47, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Disease Models, Animal; Drug Resistance, Microbial; Female; Foscarnet; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Humans; Mice; Rabbits; Reverse Transcriptase Inhibitors; Vero Cells; Virus Activation

2000
Acyclovir-resistant bilateral keratitis associated with mutations in the HSV-1 thymidine kinase gene.
    Experimental eye research, 2000, Volume: 71, Issue:4

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Amino Acid Sequence; Antiviral Agents; Base Sequence; Drug Resistance, Microbial; Female; Foscarnet; Herpesvirus 1, Human; Humans; In Situ Hybridization; Keratitis, Herpetic; Molecular Sequence Data; Point Mutation; Polymerase Chain Reaction; Thymidine Kinase; Treatment Outcome

2000
Varicella zoster meningoencephalitis following treatment for dermatomal zoster in an alloBMT patient.
    Bone marrow transplantation, 2000, Volume: 26, Issue:7

    Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; DNA, Viral; Encephalitis, Varicella Zoster; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Male; Skin Diseases; Transplantation, Homologous

2000
Resistant herpes simplex virus type 1 infection: an emerging concern after allogeneic stem cell transplantation.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2000, Volume: 31, Issue:4

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Cidofovir; Cytosine; Drug Resistance, Microbial; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Middle Aged; Organophosphonates; Organophosphorus Compounds; Transplantation, Homologous

2000
Treatment of an acyclovir and foscarnet-resistant herpes simplex virus infection with cidofovir in a child after an unrelated bone marrow transplant.
    Bone marrow transplantation, 2000, Volume: 26, Issue:8

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Cytosine; Drug Resistance; Female; Foscarnet; Herpes Simplex; Humans; Infant; Organophosphonates; Organophosphorus Compounds

2000
Extended routine polymerase chain reaction surveillance and pre-emptive antiviral therapy for cytomegalovirus after allogeneic transplantation.
    British journal of haematology, 2000, Volume: 111, Issue:3

    Topics: Acyclovir; Adolescent; Adult; Antifungal Agents; Antiviral Agents; Bone Marrow Transplantation; Cyclosporine; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Female; Fluconazole; Foscarnet; Humans; Leukemia; Lymphoma; Male; Methotrexate; Middle Aged; Polymerase Chain Reaction; Postoperative Period; Prospective Studies; Risk; Survival Rate; Time Factors; Tissue Donors; Transplantation, Homologous

2000
Acyclovir-resistant varicella infection with atypical lesions in a non-HIV leukemic infant.
    Acta paediatrica (Oslo, Norway : 1992), 2000, Volume: 89, Issue:12

    Topics: Acyclovir; Antiviral Agents; Chickenpox; Drug Resistance; Foscarnet; Herpesvirus 3, Human; HIV Seronegativity; Humans; Infant; Leukemia, Megakaryoblastic, Acute; Male; Microbial Sensitivity Tests; Regression Analysis

2000
Flow cytometric evaluation of antiviral agents against human herpesvirus 6.
    Microbiology and immunology, 2001, Volume: 45, Issue:3

    Topics: Acyclovir; Animals; Antigens, Viral; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 6, Human; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Viral Proteins

2001
Medicare may not reimburse for certain AIDS and cancer drugs.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Cytomegalovirus Retinitis; Foscarnet; Ganciclovir; Humans; Infusions, Intravenous; Insurance, Pharmaceutical Services; Medicare; Neoplasms; Vancomycin

1995
Herpesviruses.
    BETA : bulletin of experimental treatments for AIDS : a publication of the San Francisco AIDS Foundation, 1995

    Topics: 2-Aminopurine; Acyclovir; Antiviral Agents; Arabinofuranosyluracil; Cidofovir; Complementary Therapies; Cytosine; Famciclovir; Foscarnet; Herpesviridae Infections; Organophosphonates; Organophosphorus Compounds; Valacyclovir; Valine; Viral Vaccines

1995
Spectrum and treatment of cytomegalovirus disease in persons with AIDS.
    Journal of the International Association of Physicians in AIDS Care, 1996, Volume: 2, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Central Nervous System Diseases; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Digestive System Diseases; Foscarnet; Ganciclovir; Humans; Valacyclovir; Valine

1996
Herpes study and resources.
    Treatment review, 1997, Issue:No 25

    Topics: 2-Aminopurine; Acyclovir; Adult; Antiviral Agents; Biopolymers; Catechin; Clinical Trials as Topic; Complementary Therapies; Computer Communication Networks; Drug Resistance, Microbial; Famciclovir; Foscarnet; Gels; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; Humans; Middle Aged; Patient Selection; Trifluridine

1997
The potency of acyclovir can be markedly different in different cell types.
    Life sciences, 2001, Aug-03, Volume: 69, Issue:11

    Topics: Acrylates; Acyclovir; Animals; Antiviral Agents; Cells, Cultured; Chlorocebus aethiops; Dose-Response Relationship, Drug; Fibroblasts; Foscarnet; Herpesvirus 1, Human; Humans; Macrophages; Microbial Sensitivity Tests; Polymers; Vero Cells; Viral Plaque Assay; Virus Replication

2001
[Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
    Nippon Ganka Gakkai zasshi, 2000, Volume: 104, Issue:11

    Topics: Acyclovir; Adenoviridae; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Drug Evaluation, Preclinical; Foscarnet; Humans; Organophosphonates; Organophosphorus Compounds; Zalcitabine

2000
Infection due to acyclovir resistant herpes simplex virus in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Pathologie-biologie, 2001, Volume: 49, Issue:7

    Topics: Acute Disease; Acyclovir; Adolescent; Amino Acid Substitution; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Codon; Cytosine; DNA Mutational Analysis; Drug Resistance, Viral; Female; Foscarnet; Graft vs Host Disease; Herpes Simplex; Humans; Immunocompromised Host; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Mutation, Missense; Organophosphonates; Organophosphorus Compounds; Point Mutation; Salvage Therapy; Simplexvirus; Thymidine Kinase; Transplantation, Homologous; Valacyclovir; Valine; Viral Proteins; Virus Activation

2001
Successful treatment of foscarnet-resistant herpes simplex stomatitis with intravenous cidofovir in a child.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:11

    Topics: Acyclovir; Antiviral Agents; Bone Marrow Transplantation; Child; Cidofovir; Cytosine; Drug Resistance, Multiple, Viral; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Injections, Intravenous; Organophosphonates; Organophosphorus Compounds; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Stomatitis

2001
Development of acyclovir-resistant herpes simplex virus early during the treatment of herpes neonatorum.
    The Pediatric infectious disease journal, 2001, Volume: 20, Issue:11

    Topics: Acyclovir; Antiviral Agents; Autopsy; DNA, Viral; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Genotype; Herpes Simplex; Humans; Immunoenzyme Techniques; Infant, Newborn; Infectious Disease Transmission, Vertical; Male; Microbial Sensitivity Tests; Mutation; Polymerase Chain Reaction; Pregnancy; Simplexvirus; Thymidine Kinase

2001
Multiple herpes simplex virus infections with various resistance patterns in a matched unrelated donor transplant recipient.
    Bone marrow transplantation, 2001, Volume: 28, Issue:8

    Topics: Acyclovir; Antineoplastic Agents, Alkylating; Antiviral Agents; Bone Marrow Transplantation; Cidofovir; Combined Modality Therapy; Cyclosporine; Cytarabine; Cytomegalovirus Infections; Cytosine; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Herpes Genitalis; Herpes Simplex; Humans; Hydroxyurea; Immunocompromised Host; Immunosuppressive Agents; Interferons; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Organophosphonates; Organophosphorus Compounds; Simplexvirus; Transplantation Conditioning; Whole-Body Irradiation

2001
Development of drug-resistant herpes simplex virus infection after haploidentical hematopoietic progenitor cell transplantation.
    Blood, 2002, Feb-01, Volume: 99, Issue:3

    Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Viral; Female; Foscarnet; Haplotypes; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Histocompatibility; Humans; Incidence; Lymphocyte Depletion; Male; Middle Aged; Transplantation, Homologous

2002
[In vitro susceptibility study of herpes simplex virus to acyclovir and foscarnet. Are routine susceptibility studies necessary?].
    Enfermedades infecciosas y microbiologia clinica, 2002, Volume: 20, Issue:1

    Topics: Acyclovir; Antiviral Agents; Diagnostic Tests, Routine; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; Humans; Microbial Sensitivity Tests; Recurrence; Simplexvirus; Spain

2002
Drugs for non-HIV viral infections.
    The Medical letter on drugs and therapeutics, 2002, Feb-04, Volume: 44, Issue:1123

    Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Administration, Topical; Amantadine; Animals; Antiviral Agents; Cidofovir; Cytosine; Famciclovir; Foscarnet; Guanine; Herpesviridae Infections; Humans; Influenza, Human; Injections, Intravenous; Lamivudine; Organophosphonates; Organophosphorus Compounds; Rats; Ribavirin; Rimantadine; Thionucleotides; Trifluridine; Valacyclovir; Valine

2002
[Bilateral acute retinal necrosis due to herpes simplex virus in inmunocompetent people and acyclovir resistance].
    Archivos de la Sociedad Espanola de Oftalmologia, 2002, Volume: 77, Issue:6

    Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Diagnosis, Differential; Drug Therapy, Combination; Female; Foscarnet; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Necrosis; Polymerase Chain Reaction; Retina; Retinal Diseases; Time Factors

2002
The impact of transfusion of leucodepleted platelet concentrates on cytomegalovirus disease after allogeneic stem cell transplantation.
    British journal of haematology, 2002, Volume: 118, Issue:4

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus Infections; Female; Foscarnet; Ganciclovir; Humans; Infant; Lymphocyte Depletion; Male; Middle Aged; Platelet Transfusion; Postoperative Complications; Retrospective Studies; Stem Cell Transplantation; Transplantation, Homologous

2002
Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
    Journal of medical virology, 2002, Volume: 68, Issue:1

    Topics: Acyclovir; Adolescent; Animals; Antiviral Agents; Base Sequence; Bone Marrow Transplantation; Cell Line; Chlorocebus aethiops; DNA-Directed DNA Polymerase; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Male; Molecular Sequence Data; Reverse Transcriptase Inhibitors; Thymidine Kinase; Vero Cells; Virus Latency; Wiskott-Aldrich Syndrome

2002
CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
    Transplant infectious disease : an official journal of the Transplantation Society, 2002, Volume: 4, Issue:2

    Topics: Acyclovir; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus Retinitis; Female; Foscarnet; Humans; Immunosuppressive Agents; Male; Middle Aged; Time Factors

2002
Novel mutations in the thymidine kinase and DNA polymerase genes of acyclovir and foscarnet resistant herpes simplex viruses infecting an immunocompromised patient.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2002, Volume: 25, Issue:2

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genes, Viral; Herpes Genitalis; Herpesvirus 2, Human; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Molecular Sequence Data; Mutation; Sequence Analysis, DNA; Thymidine Kinase

2002
[Antiretroviral drugs for the treatment and prevention of herpes infections in the year 2000].
    Pathologie-biologie, 2002, Volume: 50, Issue:8

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Humans

2002
Progressive outer retinal necrosis in immunocompetent patients treated initially for optic neuropathy with systemic corticosteroids.
    American journal of ophthalmology, 2003, Volume: 135, Issue:4

    Topics: Acyclovir; Aged; Antiviral Agents; Aqueous Humor; Blindness; DNA, Viral; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Immunocompromised Host; Middle Aged; Multiple Sclerosis; Optic Neuritis; Polymerase Chain Reaction; Prednisone; Pupil Disorders; Retinal Necrosis Syndrome, Acute; Retrospective Studies

2003
[Acyclovir-resistant herpes exulcerans et persistens. Type II].
    Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2003, Volume: 54, Issue:4

    Topics: Acyclovir; Aged; Antiviral Agents; Drug Resistance, Microbial; Female; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; Humans; Immunocompromised Host; Leukemia, Lymphoid; Time Factors

2003
Determination of antiviral efficacy against lymphotropic herpesviruses utilizing flow cytometry.
    Antiviral research, 2003, Volume: 58, Issue:2

    Topics: Acyclovir; Antibodies, Viral; Antiviral Agents; Cells, Cultured; Cidofovir; Cytosine; Flow Cytometry; Foscarnet; Ganciclovir; Herpesvirus 4, Human; Herpesvirus 6, Human; Herpesvirus 8, Human; Humans; Organophosphonates; Organophosphorus Compounds

2003
Synergy of bovine lactoferrin with the anti-cytomegalovirus drug cidofovir in vitro.
    Antiviral research, 2003, Volume: 58, Issue:2

    Topics: Acyclovir; Animals; Antiviral Agents; Cattle; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Drug Synergism; Foscarnet; Ganciclovir; Inhibitory Concentration 50; Lactoferrin; Organophosphonates; Organophosphorus Compounds

2003
[Successful treatment with foscarnet for disseminated varicella-zoster infection after reduced intensity stem cell transplantation in a case of relapsed refractory central nervous system lymphoma].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 2003, Volume: 44, Issue:7

    Topics: Acyclovir; Adult; Antiviral Agents; Central Nervous System Neoplasms; Drug Resistance, Viral; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Humans; Lymphoma, Non-Hodgkin; Male; Recurrence; Transplantation, Homologous

2003
Development of resistance to acyclovir during chronic infection with the Oka vaccine strain of varicella-zoster virus, in an immunosuppressed child.
    The Journal of infectious diseases, 2003, Oct-01, Volume: 188, Issue:7

    Topics: Abdominal Neoplasms; Acyclovir; Antiviral Agents; Chickenpox Vaccine; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Infant; Male; Neuroblastoma; Polymorphism, Restriction Fragment Length; Vaccination; Vaccines, Attenuated

2003
Successful treatment with combination of systemic antiviral drugs and intravitreal ganciclovir injections in the management of severe necrotizing herpetic retinitis.
    Ocular immunology and inflammation, 2003, Volume: 11, Issue:2

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Drug Therapy, Combination; Female; Foscarnet; Ganciclovir; Herpes Zoster Ophthalmicus; Humans; Injections; Male; Necrosis; Retinitis; Severity of Illness Index; Visual Acuity; Vitreous Body

2003
A point mutation within conserved region VI of herpes simplex virus type 1 DNA polymerase confers altered drug sensitivity and enhances replication fidelity.
    Journal of virology, 2004, Volume: 78, Issue:2

    Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Aphidicolin; Cell Line; Chlorocebus aethiops; Conserved Sequence; DNA Replication; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Point Mutation; Sequence Alignment; Vero Cells; Viral Plaque Assay

2004
Herpes simplex virus pneumonia in a patient with ependymoma.
    Journal of pediatric hematology/oncology, 2004, Volume: 26, Issue:2

    Topics: Acyclovir; Antiviral Agents; Brain Neoplasms; Child, Preschool; Drug Therapy, Combination; Ependymoma; Fatal Outcome; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunity, Cellular; Male; Neoplasm Recurrence, Local; Pneumonia, Viral; T-Lymphocytes

2004
[Acute retinal necrosis: clinical presentation, treatment, and prognosis in a series of 22 patients].
    Journal francais d'ophtalmologie, 2004, Volume: 27, Issue:1

    Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Cytomegalovirus Retinitis; Drug Therapy, Combination; Eye Infections, Viral; Female; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Humans; Infant; Male; Middle Aged; Prognosis; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Visual Acuity; Vitreoretinopathy, Proliferative

2004
[Infection due to acyclovir-resistant varicella-zoster herpes virus in a patient with AIDS].
    Enfermedades infecciosas y microbiologia clinica, 2004, Volume: 22, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Fatal Outcome; Female; Foscarnet; Herpes Zoster; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Organophosphonates

2004
In vitro efficacy of ganciclovir, cidofovir, penciclovir, foscarnet, idoxuridine, and acyclovir against feline herpesvirus type-1.
    American journal of veterinary research, 2004, Volume: 65, Issue:4

    Topics: Acyclovir; Animals; Antiviral Agents; Cats; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Foscarnet; Ganciclovir; Guanine; Idoxuridine; In Vitro Techniques; Inhibitory Concentration 50; Organophosphonates; Organophosphorus Compounds; Varicellovirus; Virus Replication

2004
ELVIRA HSV, a yield reduction assay for rapid herpes simplex virus susceptibility testing.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Acyclovir; Antiviral Agents; Colorimetry; Drug Evaluation, Preclinical; Foscarnet; Genes, Reporter; Lac Operon; Simplexvirus; Viral Plaque Assay; Virus Replication

2004
In vitro selection of drug-resistant varicella-zoster virus (VZV) mutants (OKA strain): differences between acyclovir and penciclovir?
    Antiviral research, 2004, Volume: 61, Issue:3

    Topics: 2-Aminopurine; Acyclovir; Adenine; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Drug Resistance, Viral; Foscarnet; Guanine; Herpesvirus 3, Human; Humans; Microbial Sensitivity Tests; Mutation; Organophosphonates; Phenotype; Selection, Genetic; Thymidine Kinase; Viral Proteins

2004
A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-15, Volume: 40, Issue:10

    Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Female; Foscarnet; Herpes Zoster Oticus; Herpesvirus 2, Human; Humans; Syndrome; Valacyclovir; Valine

2005
S-adenosyl methionine decarboxylase activity is required for the outcome of herpes simplex virus type 1 infection and represents a new potential therapeutic target.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:9

    Topics: Acyclovir; Adenosylmethionine Decarboxylase; Antiviral Agents; Cell Line; Cell Proliferation; Enzyme Inhibitors; Foscarnet; Gene Expression Regulation, Enzymologic; Herpes Simplex; Herpesvirus 1, Human; Humans; Mitoguazone; RNA, Messenger; Spermine; Virus Replication

2005
Intravenous foscarnet in the management of acyclovir-resistant herpes simplex virus type 2 in acute retinal necrosis in children.
    Medical science monitor : international medical journal of experimental and clinical research, 2005, Volume: 11, Issue:12

    Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Drug Resistance, Viral; Female; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; Humans; Injections, Intravenous; Retinal Necrosis Syndrome, Acute

2005
Synergistic in vitro interactions between (22S,23S)-3beta-bromo-5alpha,22,23-trihydroxystigmastan-6-one and acyclovir or foscarnet against herpes simplex virus type 1.
    Chemotherapy, 2006, Volume: 52, Issue:1

    Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; Cell Proliferation; Chlorocebus aethiops; Cholestanones; Drug Synergism; Foscarnet; Herpesvirus 1, Human; Molecular Structure

2006
Rapid determination of antiviral drug susceptibility of herpes simplex virus types 1 and 2 by real-time PCR.
    Antiviral research, 2006, Volume: 69, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; DNA, Viral; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Herpesvirus 2, Human; Microbial Sensitivity Tests; Polymerase Chain Reaction; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Vero Cells; Viral Plaque Assay; Virus Replication

2006
Imiquimod 5% cream for the treatment of recurrent, acyclovir-resistant genital herpes.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Feb-15, Volume: 42, Issue:4

    Topics: Acyclovir; Administration, Topical; Aged; Aminoquinolines; Antiviral Agents; Arthritis, Rheumatoid; Drug Resistance, Viral; Emollients; Female; Foscarnet; Herpes Genitalis; Humans; Imiquimod; Infusions, Intravenous; Treatment Outcome; Trifluridine; Valacyclovir; Valine

2006
Chronic hypertrophic acyclovir-resistant genital herpes treated with topical cidofovir and with topical foscarnet at recurrence in an HIV-positive man.
    Journal of the European Academy of Dermatology and Venereology : JEADV, 2006, Volume: 20, Issue:7

    Topics: Acyclovir; Administration, Topical; Antiretroviral Therapy, Highly Active; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Therapy, Combination; Foscarnet; Herpes Genitalis; HIV Infections; Humans; Male; Middle Aged; Organophosphonates

2006
In vitro susceptibility of six isolates of equine herpesvirus 1 to acyclovir, ganciclovir, cidofovir, adefovir, PMEDAP and foscarnet.
    Veterinary microbiology, 2007, May-16, Volume: 122, Issue:1-2

    Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; Dose-Response Relationship, Drug; Drug Resistance, Viral; Epithelial Cells; Foscarnet; Ganciclovir; Herpesvirus 1, Equid; Horses; Lung; Organophosphonates

2007
Successful liver transplantation in a kidney and pancreas allograft recipient with fulminant herpes simplex virus type 2 hepatitis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2007, Volume: 22, Issue:11

    Topics: Acyclovir; Adult; Antiviral Agents; Biopsy, Needle; Female; Foscarnet; Hepatitis, Viral, Human; Herpes Simplex; Herpesvirus 2, Human; Humans; Kidney Transplantation; Liver; Liver Transplantation; Pancreas Transplantation; Transplantation, Homologous; Treatment Outcome

2007
Hydroxyurea enhances the activity of acyclovir and cidofovir against herpes simplex virus type 1 resistant strains harboring mutations in the thymidine kinase and/or the DNA polymerase genes.
    Antiviral research, 2008, Volume: 77, Issue:1

    Topics: Acyclovir; Antiviral Agents; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Combinations; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Hydroxyurea; Mutation; Organophosphonates; Ribonucleotide Reductases; Thymidine Kinase

2008
Macular optical coherence tomography findings in progressive outer retinal necrosis.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2007, Volume: 42, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Acyclovir; Antiviral Agents; Aqueous Humor; DNA, Viral; Drug Therapy, Combination; Female; Fluorescein Angiography; Foscarnet; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Macula Lutea; Middle Aged; Polymerase Chain Reaction; Retinal Necrosis Syndrome, Acute; Tomography, Optical Coherence

2007
Acute retinal necrosis.
    Ophthalmology, 2008, Volume: 115, Issue:6

    Topics: Acyclovir; Antiviral Agents; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Foscarnet; Humans; Laser Coagulation; Polymerase Chain Reaction; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Valacyclovir; Valine; Vitrectomy; Vitreous Body

2008
Acyclovir-resistant corneal HSV-1 isolates from patients with herpetic keratitis.
    The Journal of infectious diseases, 2008, Sep-01, Volume: 198, Issue:5

    Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cohort Studies; Cornea; Drug Resistance, Multiple, Viral; Female; Foscarnet; Ganciclovir; Herpesvirus 1, Human; Humans; Keratitis, Herpetic; Male; Middle Aged; Prevalence; Thymidine Kinase

2008
Donor CMV serostatus not predictive of relapse in D-/R- pediatric HCT.
    Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation, 2009, Volume: 15, Issue:6

    Topics: Acyclovir; Adolescent; Adult; Antibodies, Viral; Antigens, Viral; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ethnicity; Female; Foscarnet; Ganciclovir; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Infant; Infant, Newborn; Living Donors; Male; Middle Aged; Myeloablative Agonists; Postoperative Complications; Premedication; Proportional Hazards Models; Recurrence; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Virus Activation; Young Adult

2009
[Inhibitory effect of foscarnet and acyclovir on reproduction of human herpesvirus 6 in cell culture].
    Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 2009, Volume: 54, Issue:1-2

    Topics: Acyclovir; Antiviral Agents; Cell Line, Tumor; Cell Survival; Cytopathogenic Effect, Viral; Dose-Response Relationship, Drug; Foscarnet; Herpesvirus 6, Human; Humans; Virus Replication

2009
Engineering of a chimeric RB69 DNA polymerase sensitive to drugs targeting the cytomegalovirus enzyme.
    The Journal of biological chemistry, 2009, Sep-25, Volume: 284, Issue:39

    Topics: Acyclovir; Antiviral Agents; Binding Sites; Catalysis; Cytomegalovirus; Deoxycytosine Nucleotides; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Kinetics; Models, Molecular; Molecular Structure; Protein Engineering; Protein Structure, Tertiary; Recombinant Fusion Proteins; Viral Proteins

2009
Acute retinal necrosis: the effects of intravitreal foscarnet and virus type on outcome.
    Ophthalmology, 2010, Volume: 117, Issue:3

    Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Eye Infections, Viral; Female; Foscarnet; Herpes Simplex; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Infusions, Intravenous; Male; Middle Aged; Polymerase Chain Reaction; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Visual Acuity; Vitreous Body; Young Adult

2010
Phenotypic and genotypic characterization of acyclovir-resistant clinical isolates of herpes simplex virus.
    Antiviral research, 2010, Volume: 86, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Survival; Cells, Cultured; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Guanine; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Microbial Sensitivity Tests; Mutation, Missense; Organophosphonates; Oxidation-Reduction; Sequence Analysis, DNA; Staining and Labeling; Tetrazolium Salts; Thymidine Kinase; Viral Proteins

2010
Resistant herpes simplex keratitis.
    Clinical & experimental ophthalmology, 2010, Volume: 38, Issue:3

    Topics: Acyclovir; Antiviral Agents; Corneal Diseases; Drug Resistance, Viral; Foscarnet; Humans; Keratitis, Herpetic; Treatment Failure; Treatment Outcome; Vidarabine

2010
Phenotypic and genetic characterization of varicella-zoster virus mutants resistant to acyclovir, brivudine and/or foscarnet.
    Medical microbiology and immunology, 2011, Volume: 200, Issue:3

    Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Bromodeoxyuridine; Cell Line; Drug Resistance, Viral; Evolution, Molecular; Foscarnet; Genes, Viral; Herpes Zoster; Herpesvirus 3, Human; Humans; Inhibitory Concentration 50; Microbial Sensitivity Tests; Mutation; Open Reading Frames; Thymidine Kinase; Virus Replication

2011
Inhibitory activities of microalgal extracts against Epstein-Barr virus DNA release from lymphoblastoid cells.
    Journal of Zhejiang University. Science. B, 2011, Volume: 12, Issue:5

    Topics: Acyclovir; Antiviral Agents; Base Sequence; Burkitt Lymphoma; Cell Line, Tumor; Chlorophyta; DNA, Viral; Foscarnet; Herpesvirus 4, Human; Humans; Lymphoid Progenitor Cells; Microalgae; Polymerase Chain Reaction; Spirulina; Synechococcus; Viral Load

2011
Phosphonoformic acid inhibits viral replication by trapping the closed form of the DNA polymerase.
    The Journal of biological chemistry, 2011, Jul-15, Volume: 286, Issue:28

    Topics: Acyclovir; Amino Acid Substitution; Crystallography, X-Ray; Cytomegalovirus; DNA-Directed DNA Polymerase; Foscarnet; Humans; Models, Molecular; Point Mutation; Protein Structure, Tertiary; Viral Proteins

2011
Intravitreal foscarnet for the treatment of acyclovir-resistant acute retinal necrosis caused by varicella zoster virus.
    Ocular immunology and inflammation, 2011, Volume: 19, Issue:3

    Topics: Acyclovir; Adult; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Injections, Intravenous; Intravitreal Injections; Male; Retinal Necrosis Syndrome, Acute; Treatment Outcome

2011
Extensive oral herpes simplex virus type 1 infection in a haematopoietic stem cell transplant recipient not responding to aciclovir.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 52, Issue:2

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Hodgkin Disease; Humans; Male; Middle Aged; Mouth; Treatment Outcome

2011
Novel resistance-associated mutations of thymidine kinase and DNA polymerase genes of herpes simplex virus type 1 and type 2.
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Acyclovir; Adolescent; Adult; Aged; Antiviral Agents; Bromodeoxyuridine; Child; Child, Preschool; Cidofovir; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genotype; Guanine; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Infant; Male; Middle Aged; Mutation; Organophosphonates; Sequence Analysis, DNA; Thymidine Kinase; Viral Proteins

2011
Successful treatment of aciclovir and foscarnet resistant Herpes simplex virus lesions with topical imiquimod in patients infected with human immunodeficiency virus type 1.
    Journal of medical virology, 2012, Volume: 84, Issue:2

    Topics: Acyclovir; Administration, Topical; Adult; Aminoquinolines; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; HIV Infections; HIV-1; Humans; Imiquimod; Lamivudine; Male; Middle Aged; Nelfinavir; Simplexvirus; Zidovudine

2012
Polymorphic ventricular tachycardia in a patient with herpes encephalitis.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:3

    Topics: Acute Disease; Acyclovir; Antiviral Agents; Defibrillators, Implantable; Electrocardiography; Encephalitis, Herpes Simplex; Female; Foscarnet; Ganciclovir; Headache; Heart Arrest; Herpesvirus 2, Human; Humans; Long QT Syndrome; Magnetic Resonance Imaging; Meningitis, Viral; Middle Aged; Seizures; Tachycardia, Ventricular; Torsades de Pointes

2012
Successful clearance of cutaneous acyclovir-resistant, foscarnet-refractory herpes virus lesions with topical cidofovir in an allogeneic hematopoietic stem cell transplant patient.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:2

    Topics: Acyclovir; Administration, Topical; Adult; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Foscarnet; Gels; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Organophosphonates; Real-Time Polymerase Chain Reaction; Transplantation, Homologous; Treatment Outcome

2013
Rapid susceptibility testing for herpes simplex virus type 1 using real-time PCR.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2013, Volume: 56, Issue:1

    Topics: Acyclovir; Antiviral Agents; DNA, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Microbial Sensitivity Tests; Real-Time Polymerase Chain Reaction; Time Factors

2013
Surveillance of herpes simplex virus resistance to antivirals: a 4-year survey.
    Antiviral research, 2013, Volume: 100, Issue:2

    Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Epidemiological Monitoring; Female; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Prevalence; Retrospective Studies; Viral Proteins; Young Adult

2013
Acyclovir-resistant herpes simplex encephalitis in a patient treated with anti-tumor necrosis factor-α monoclonal antibodies.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2014, Volume: 59, Issue:1

    Topics: Acyclovir; Adalimumab; Antibodies, Monoclonal, Humanized; Cerebrospinal Fluid; Drug Resistance, Viral; Encephalitis, Herpes Simplex; Female; Foscarnet; Humans; Immunosuppressive Agents; Middle Aged; Simplexvirus; Treatment Outcome

2014
Long-term follow-up of HIV-infected patients once diagnosed with acyclovir-resistant herpes simplex virus infection.
    International journal of STD & AIDS, 2014, Volume: 25, Issue:9

    Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; Cidofovir; Cytosine; Drug Resistance, Viral; Female; Follow-Up Studies; Foscarnet; Herpes Simplex; HIV Infections; Humans; Immunocompromised Host; Male; Middle Aged; Organophosphonates; Retrospective Studies; Skin Diseases, Viral; Skin Ulcer; Socioeconomic Factors; Thymidine Kinase; Treatment Outcome

2014
β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
    Antiviral research, 2014, Volume: 110

    Topics: Acyclovir; Animals; Antiviral Agents; Bromodeoxyuridine; Cell Line; Chickenpox; Dioxolanes; Drug Therapy, Combination; Fluorouracil; Foscarnet; Herpes Zoster; Herpesvirus 3, Human; Humans; Mice; Mice, Inbred BALB C; Mice, SCID; Nucleosides; Organ Culture Techniques; Skin; Uracil; Virus Replication

2014
Simultaneous titration and phenotypic antiviral drug susceptibility testing for herpes simplex virus 1 and 2.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2014, Volume: 61, Issue:3

    Topics: Acyclovir; Animals; Antiviral Agents; Cell Line; Cell Survival; Cytopathogenic Effect, Viral; Foscarnet; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Inhibitory Concentration 50; Luminescent Measurements; Microbial Sensitivity Tests; Reproducibility of Results; Viral Load

2014
Spectrum of activity and mechanisms of resistance of various nucleoside derivatives against gammaherpesviruses.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Acyclovir; Amino Acid Sequence; Animals; Antiviral Agents; Arabinofuranosyluracil; Bromodeoxyuridine; Cytarabine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Guanine; Herpesvirus 4, Human; Herpesvirus 8, Human; Humans; Molecular Sequence Data; Protein Kinases; Rhadinovirus; Sequence Alignment; Structure-Activity Relationship; Thymidine Kinase; Viral Proteins

2014
Contrasting effects of W781V and W780V mutations in helix N of herpes simplex virus 1 and human cytomegalovirus DNA polymerases on antiviral drug susceptibility.
    Journal of virology, 2015, Volume: 89, Issue:8

    Topics: Acyclovir; Analysis of Variance; Animals; Antiviral Agents; Chlorocebus aethiops; Cytomegalovirus; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Ganciclovir; Gene Transfer Techniques; Herpesvirus 1, Human; Humans; Kinetics; Models, Molecular; Mutation, Missense; Protein Structure, Secondary; Vero Cells

2015
[Research of suppression of the herpes simplex virus reproduction with drug resistance by combination phosphite of acycloguanosine with some antiherpetic drugs].
    Voprosy virusologii, 2014, Volume: 59, Issue:6

    Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; Cytosine; Drug Resistance, Viral; Drug Synergism; Drug Therapy, Combination; Foscarnet; Glycyrrhizic Acid; Herpesvirus 1, Human; Humans; Interferon-alpha; Organophosphonates; Phosphites; Ribavirin; Vero Cells; Vidarabine; Virus Replication

2014
Sequence Analysis of Herpes Simplex Virus 1 Thymidine Kinase and DNA Polymerase Genes from over 300 Clinical Isolates from 1973 to 2014 Finds Novel Mutations That May Be Relevant for Development of Antiviral Resistance.
    Antimicrobial agents and chemotherapy, 2015, Volume: 59, Issue:8

    Topics: Acyclovir; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Child; Child, Preschool; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Female; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Humans; Infant; Infant, Newborn; Male; Middle Aged; Mutation; Polymorphism, Genetic; Retrospective Studies; Sequence Analysis, DNA; Thymidine Kinase; Viral Proteins; Young Adult

2015
Chorioretinitis with exudative retinal detachment secondary to varicella zoster virus.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 2015, Volume: 50, Issue:5

    Topics: Acyclovir; Administration, Oral; Antiviral Agents; Chorioretinitis; Drug Combinations; Exudates and Transudates; Eye Infections, Viral; Fluorescein Angiography; Foscarnet; Glucocorticoids; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmic Solutions; Parasympatholytics; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Tropanes; Valacyclovir; Valine

2015
Effects of Acyclovir, Foscarnet, and Ribonucleotides on Herpes Simplex Virus-1 DNA Polymerase: Mechanistic Insights and a Novel Mechanism for Preventing Stable Incorporation of Ribonucleotides into DNA.
    Biochemistry, 2016, Feb-23, Volume: 55, Issue:7

    Topics: Acyclovir; Antiviral Agents; Catalytic Domain; DNA-Directed DNA Polymerase; DNA, Single-Stranded; Exodeoxyribonucleases; Foscarnet; Herpesvirus 1, Human; Hydrolysis; Kinetics; Models, Molecular; Molecular Structure; Nucleic Acid Synthesis Inhibitors; Recombinant Proteins; Ribonucleotides; Substrate Specificity; Viral Proteins

2016
A unique presentation of acute liver failure from herpes simplex virus hepatitis.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:4

    Topics: Acyclovir; Adrenal Cortex Hormones; Antiviral Agents; Bone Marrow Transplantation; Drug Resistance, Viral; Fatal Outcome; Foscarnet; Graft vs Host Disease; Hepatitis, Viral, Human; Humans; Liver; Liver Failure, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Patient Comfort; Polymerase Chain Reaction; Simplexvirus; Transaminases; Transplantation, Homologous; Valacyclovir; Valine

2016
Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antineoplastic Agents; Antiviral Agents; Cytosine; Drug Resistance, Viral; Drugs, Investigational; Female; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Immunocompromised Host; Investigational New Drug Application; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Organophosphonates; Transplantation, Homologous; Valacyclovir; Valine

2016
Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation.
    Transplant infectious disease : an official journal of the Transplantation Society, 2016, Volume: 18, Issue:5

    Topics: Acyclovir; Adenoviridae; Adenovirus Infections, Human; Antibiotic Prophylaxis; Antiviral Agents; Child, Preschool; Cidofovir; Cytosine; DNA, Viral; Drug Resistance, Viral; Epstein-Barr Virus Infections; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpes Zoster; Herpesvirus 1, Human; Herpesvirus 3, Human; Herpesvirus 4, Human; Humans; Immunocompromised Host; Meningoencephalitis; Mucositis; Myelodysplastic Syndromes; Organophosphonates; Rituximab; Viral Load

2016
Acyclovir resistance in herpes simplex virus type I encephalitis: a case report.
    Journal of neurovirology, 2017, Volume: 23, Issue:2

    Topics: Acyclovir; Antiviral Agents; Disease Progression; Drug Resistance, Viral; Drug Substitution; Encephalitis, Herpes Simplex; Female; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Leukocytosis; Magnetic Resonance Imaging; Middle Aged; Temporal Lobe

2017
The Successful Treatment of a Cord Blood Transplant Recipient with Varicella Zoster Virus Meningitis, Radiculitis and Myelitis with Foscarnet.
    Internal medicine (Tokyo, Japan), 2017, Volume: 56, Issue:3

    Topics: Acyclovir; Antiviral Agents; Foscarnet; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Herpes Zoster; Herpesvirus 3, Human; Humans; Meningitis, Viral; Transplantation, Homologous

2017
Recurrent Herpes Labialis in Adults: New Tricks for an Old Dog.
    Journal of drugs in dermatology : JDD, 2017, Mar-01, Volume: 16, Issue:3

    Topics: Acyclovir; Administration, Oral; Administration, Topical; Adult; Antiviral Agents; Chronic Disease; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpes Labialis; Herpesvirus 1, Human; Humans; Hyperthermia, Induced; Infusions, Parenteral; Organophosphonates; Recurrence; Stomatitis, Herpetic; Viral Load

2017
High-dose acyclovir combined with foscavir (foscarnet) in the management of severe herpes simplex virus meningoencephalitis.
    Revue neurologique, 2017, Volume: 173, Issue:4

    Topics: Acyclovir; Adolescent; Antiviral Agents; Brain; Drug Therapy, Combination; Encephalitis, Herpes Simplex; Foscarnet; Glasgow Coma Scale; Humans; Magnetic Resonance Imaging; Male; Paresthesia; Treatment Outcome

2017
New modified 2-aminobenzimidazole nucleosides: Synthesis and evaluation of their activity against herpes simplex virus type 1.
    Bioorganic & medicinal chemistry letters, 2017, 06-01, Volume: 27, Issue:11

    Topics: Acyclovir; Antiviral Agents; Benzimidazoles; Cidofovir; Cytosine; Drug Resistance, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Nucleosides; Organophosphonates

2017
Surgical excision for recurrent herpes simplex virus 2 (HSV-2) anogenital infection in a patient with human immunodeficiency virus (HIV).
    Infection, 2017, Volume: 45, Issue:5

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; Humans; Male; Middle Aged

2017
Verrucous herpes of the finger in a patient with HIV-1 infection.
    Infection, 2018, Volume: 46, Issue:2

    Topics: Acyclovir; Administration, Intravenous; Administration, Oral; Antiviral Agents; Fingers; Foscarnet; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; Humans; Male; Middle Aged

2018
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
    The Journal of infectious diseases, 2018, 02-14, Volume: 217, Issue:5

    Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Cells, Cultured; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Mutation, Missense; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Selection, Genetic; Sequence Analysis, DNA; Tenofovir; Viral Proteins

2018
[Acyclovir-resistant perineal HSV infection revealing chronic lymphoid leukaemia].
    Annales de dermatologie et de venereologie, 2018, Volume: 145, Issue:3

    Topics: Acyclovir; Adjuvants, Immunologic; Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antiviral Agents; Female; Foscarnet; Herpes Simplex; Humans; Imiquimod; Immunocompromised Host; Leukemia, Lymphocytic, Chronic, B-Cell; Perineum

2018
Improvement of refractory acyclovir-resistant herpes simplex virus type 1 infection by continuous acyclovir administration.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2019, Volume: 25, Issue:1

    Topics: Acyclovir; Antiviral Agents; Child; Drug Resistance, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Infusions, Intravenous; Leukemia, Monocytic, Acute; Lip; Mutation

2019
Acyclovir Unresponsive Herpes Simplex Encephalitis in a child successfully treated with the addition of Foscarnet: Case report.
    Archivos argentinos de pediatria, 2019, 02-01, Volume: 117, Issue:1

    Topics: Acyclovir; Antiviral Agents; Child; Drug Combinations; Drug Resistance, Viral; Encephalitis, Herpes Simplex; Foscarnet; Humans; Male; Remission Induction; Simplexvirus; Treatment Failure

2019
Acute retinal necrosis in a patient with remote severe herpes simplex encephalitis.
    BMJ case reports, 2019, May-27, Volume: 12, Issue:5

    Topics: Acute Disease; Acyclovir; Antiviral Agents; Diagnosis, Differential; Encephalitis, Herpes Simplex; Eye Infections, Viral; Foscarnet; Herpesvirus 1, Human; Humans; Intravitreal Injections; Male; Middle Aged; Ophthalmoscopes; Rare Diseases; Retinal Necrosis Syndrome, Acute; Treatment Outcome; Valacyclovir

2019
Topical Treatment of Acyclovir-Resistant Herpes Simplex Virus Stomatitis after Allogeneic Hematopoietic Cell Transplantation.
    Oncology research and treatment, 2020, Volume: 43, Issue:12

    Topics: Acyclovir; Administration, Topical; Adult; Aged; Antiviral Agents; Cidofovir; Drug Resistance, Viral; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Herpesvirus 1, Human; Humans; Leukemia, Myeloid, Acute; Male; Middle Aged; Stomatitis; Treatment Outcome

2020
[Herpes simplex virus resistance to antivirals].
    Virologie (Montrouge, France), 2020, Oct-01, Volume: 24, Issue:5

    Topics: Acyclovir; Antiviral Agents; Foscarnet; Herpes Simplex; Humans; Simplexvirus

2020
RECURRENT ACUTE RETINAL NECROSIS.
    Retinal cases & brief reports, 2022, 11-01, Volume: 16, Issue:6

    Topics: Acyclovir; Antiviral Agents; Child, Preschool; Female; Foscarnet; Humans; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Valacyclovir

2022
Acute HSV and anti-NMDA encephalitis occurring as a neurosurgical complication.
    BMJ case reports, 2021, May-26, Volume: 14, Issue:5

    Topics: Acyclovir; Adult; Antiviral Agents; Encephalitis, Herpes Simplex; Foscarnet; Humans; Male; Neoplasm Recurrence, Local; Young Adult

2021
ACUTE RETINAL NECROSIS: Difference in Outcome by Viral Type and Options for Antiviral Therapy.
    Retina (Philadelphia, Pa.), 2021, Jul-01, Volume: 41, Issue:7

    Topics: Acyclovir; Adult; Aged; Aged, 80 and over; Antiviral Agents; DNA, Viral; Eye Infections, Viral; Female; Follow-Up Studies; Foscarnet; Herpes Zoster Ophthalmicus; Herpesvirus 3, Human; Humans; Male; Middle Aged; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Treatment Outcome; Visual Acuity

2021
Antiviral susceptibility of recombinant Herpes simplex virus 1 strains with specific polymerase amino acid changes.
    Antiviral research, 2021, Volume: 195

    Topics: Acyclovir; Animals; Antiviral Agents; Chlorocebus aethiops; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Guanine; Herpes Simplex; Herpesvirus 1, Human; Humans; Immunocompromised Host; Microbial Sensitivity Tests; Thymidine Kinase; Vero Cells

2021
Acyclovir-Resistant Cutaneous Herpes Simplex Virus in DOCK8 Deficiency.
    Cutis, 2021, Volume: 108, Issue:4

    Topics: Acyclovir; Antiviral Agents; Child, Preschool; Drug Resistance, Viral; Female; Foscarnet; Guanine Nucleotide Exchange Factors; Herpes Simplex; Humans; Simplexvirus

2021
Unusual oral presentation of acyclovir-resistant herpes simplex in an allogeneic haematopoietic stem cell transplant recipient.
    BMJ case reports, 2021, Dec-30, Volume: 14, Issue:12

    Topics: Acyclovir; Adult; Antiviral Agents; Female; Foscarnet; Hematopoietic Stem Cell Transplantation; Herpes Simplex; Humans

2021
Novel mutations in antiviral multiresistant HSV-2 genital lesion: A case report.
    Journal of medical virology, 2022, Volume: 94, Issue:12

    Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Genitalia; Herpes Simplex; Herpesvirus 2, Human; Humans; Imiquimod; Mutation; Obesity; Thymidine Kinase; Valacyclovir

2022
Heterogeneity and viral replication fitness of HSV-1 clinical isolates with mutations in the thymidine kinase and DNA polymerase.
    The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11

    Topics: Acyclovir; Antiviral Agents; Cidofovir; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Mutation; Thymidine Kinase; Virus Replication

2022
[Severe Encephalitis with Human Herpes Virus-7 (HHV-7) Associated Transient Splenial Lesion in an Immunocompetent Child: A Case Report].
    Mikrobiyoloji bulteni, 2023, Volume: 57, Issue:2

    Topics: Acyclovir; Antiviral Agents; Child; Encephalitis; Female; Foscarnet; Herpesvirus 7, Human; Humans; Infant

2023
A case report of long-delayed diagnosis of pseudorabies virus encephalitis with endophthalmitis: lessons from metagenomic next generation sequencing.
    BMC neurology, 2023, May-16, Volume: 23, Issue:1

    Topics: Acyclovir; Antiviral Agents; Aqueous Humor; Blindness; Delayed Diagnosis; DNA, Viral; Encephalitis, Viral; Endophthalmitis; Foscarnet; Herpesvirus 1, Suid; High-Throughput Nucleotide Sequencing; Humans; Male; Metagenomics; Methylprednisolone; Middle Aged; Pseudorabies

2023
Novel UL23 and UL30 substitutions in HSV1 and HSV2 viruses related to polymorphism or drug resistance.
    Antiviral research, 2023, Volume: 216

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Herpes Simplex; Herpesvirus 1, Human; Humans; Viral Proteins

2023
Genotypic testing improves detection of antiviral resistance in human herpes simplex virus.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2023, Volume: 167

    Topics: Acyclovir; Antiviral Agents; Drug Resistance, Viral; Foscarnet; Genotype; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans

2023